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significance beyond simple information storage. This versatility arises from enzymes that chemically modify
cytosine to expand the potential of the genome. Cytosine can be methylated, oxidized, and deaminated to
modulate transcription and immunologic diversity. At the crossroads of these modifications sit the AID/
APOBEC family deaminases, which accomplish diverse functions ranging from antibody diversification and
innate immunity to mRNA editing. In addition, novel roles have been proposed in oncogenesis and DNA
demethylation. Behind these established and emerging physiologic activities remain important questions
about the substrate specificity of these deaminases, reflecting a broader need to elucidate how AID/APOBEC
enzymes engage their substrates for deamination. The work here addresses this larger question by focusing on
the molecular basis of two important aspects of AID/APOBEC specificity: selectivity for DNA over RNA,
and biochemical plausibility of deamination-coupled demethylation. To address these questions, we have
synthesized chimeric nucleic acid substrates and characterized their reactivity with AID and the rest of the
APOBEC family. With regards to nucleic acid selectivity, modifications to the 2'-position of the target
nucleotide sugar significantly alter AID's reactivity. Strikingly, within a substrate that is otherwise DNA, a
single RNA-like 2'-hydroxyl substitution at the target cytosine is sufficient to compromise deamination.
Alternatively, modifications that favor a DNA-like conformation (or sugar pucker) are compatible with
deamination. Inversely, with unreactive 2'-fluoro-RNA substrates, AID's deaminase activity was rescued by
introducing a trinucleotide DNA patch spanning the target cytosine and two upstream nucleotides. With
regards to demethylation, AID has substantially reduced activity on 5-methylcytosine relative to cytosine, its
canonical substrate, and no detectable deamination of 5-hydroxymethylcytosine. This finding is explained by
the reactivity of a series of modified substrates, where steric bulk at the 5-position was increasingly
detrimental to deamination. We found that these nucleic acid determinants, localized to the nucleotide base
and sugar, are conserved across the entire AID/APOBEC family. Taken together, we consolidate these
findings into a unifying, mechanistic model for substrate engagement that clarifies the established and
proposed functions of the AID/APOBEC family.
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ABSTRACT 
NUCLEIC ACID DETERMINANTS OF CYTOSINE DEAMINATION BY AID/APOBEC ENZYMES 
IN IMMUNITY AND EPIGENETICS 
Christopher S. Nabel 
Rahul M. Kohli 
A multitude of functions have evolved around cytosine within DNA, endowing the base with 
physiological significance beyond simple information storage.  This versatility arises from 
enzymes that chemically modify cytosine to expand the potential of the genome.  Cytosine can be 
methylated, oxidized, and deaminated to modulate transcription and immunologic diversity.  At 
the crossroads of these modifications sit the AID/APOBEC family deaminases, which accomplish 
diverse functions ranging from antibody diversification and innate immunity to mRNA editing.  In 
addition, novel roles have been proposed in oncogenesis and DNA demethylation.  Behind these 
established and emerging physiologic activities remain important questions about the substrate 
specificity of these deaminases, reflecting a broader need to elucidate how AID/APOBEC 
enzymes engage their substrates for deamination.  The work here addresses this larger question 
by focusing on the molecular basis of two important aspects of AID/APOBEC specificity: 
selectivity for DNA over RNA, and biochemical plausibility of deamination-coupled demethylation.  
To address these questions, we have synthesized chimeric nucleic acid substrates and 
characterized their reactivity with AID and the rest of the APOBEC family.  With regards to nucleic 
acid selectivity, modifications to the 2’-position of the target nucleotide sugar significantly alter 
AID’s reactivity.  Strikingly, within a substrate that is otherwise DNA, a single RNA-like 2'-hydroxyl 
substitution at the target cytosine is sufficient to compromise deamination.  Alternatively, 
modifications that favor a DNA-like conformation (or sugar pucker) are compatible with 
deamination.  Inversely, with unreactive 2'-fluoro-RNA substrates, AID’s deaminase activity was 
rescued by introducing a trinucleotide DNA patch spanning the target cytosine and two upstream 
nucleotides.  With regards to demethylation, AID has substantially reduced activity on 5-
methylcytosine relative to cytosine, its canonical substrate, and no detectable deamination of 5-
v	  
	  
hydroxymethylcytosine.  This finding is explained by the reactivity of a series of modified 
substrates, where steric bulk at the 5-position was increasingly detrimental to deamination.  We 
found that these nucleic acid determinants, localized to the nucleotide base and sugar, are 
conserved across the entire AID/APOBEC family.  Taken together, we consolidate these findings 
into a unifying, mechanistic model for substrate engagement that clarifies the established and 
proposed functions of the AID/APOBEC family. 
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CHAPTER 1: INTRODUCTION	  
1.1 Cytosine Modifications in DNA	  
1.1.1 Chemical Modification of Cytosine Transforms Genomic Potential	  
  In the conventional view, the genome is a long polymer of A, C, G, and T, which together 
define and differentiate organisms.  We typically think of the genome as a stable, unchanging 
blueprint for life.  However, as life demands variety and adaptability, it has become increasingly 
clear that diversity within an organism is governed by the dynamic changes that occur within this 
genomic scaffold (1).  In particular, enzymes that chemically modify cytosine introduce a 
physiologically important layer of complexity to the genome, beyond that seen in the primary 
sequence [Figure 1]. 
 
Figure 1: Cytosine as the Genomic “Wild Card”. Within the context of the genome, cytosine 
can be modified by deamination, methylation, oxidation or demethylation to generate a series of 
analogs. In turn, these cytosine modifications influence coding sequences, gene expression and 
cellular identity. Amongst these analogs, enzymatic modifications can generate 5-methylcytosine 
(mC), 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC), 5-carboxycytosine (caC), 5-
hydroxymethyluracil (hmU) and uracil (U) and thymine (T). 
 
These accessory functions to the genome mediate critical physiologic processes across 
all walks of life.  For example, modification of DNA can help organisms distinguish self DNA from 
foreign DNA (2).  In bacterial species, DNA methyltransferases have coevolved with partner 
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restriction endonucleases that share the same sequence preference.  Since only host DNA is 
methylated, this system allows for degradation of foreign DNA by the corresponding restriction 
enzyme.  A second adaptive role for DNA modification is to mediate the expression or silencing of 
genes (3).  While DNA modifications share this role with histone modification enzymes, all are 
needed in order to properly modulate transcriptional networks.  Importantly, DNA-modifying 
enzymes also allow for the reverse process to occur, ‘resetting’ the genome for proper 
gametogenesis or reactivation of gene expression (4).  Finally, the mammalian adaptive immune 
system demonstrates the importance of genomic malleability. The immunoglobulin (Ig) locus is a 
dramatic example of how the genome is preprogrammed to foster variety, through recombination 
and mutation that ultimately confer an adaptive advantage (5, 6).  In order to examine the 
relevant biological pathways, we must first introduce the enzymes in nature’ s toolbox for altering 
cytosine within DNA. 
1.1.2 Chemical Reactivity of Cytosine 
In duplex DNA, the C5 and C6 positions of cytosine lie in the major groove, unobstructed 
by Watson-Crick interactions.  The electrophilic character of the C6 position makes it a key target 
of modifying enzymes.  For example, DNA methyltransferases (DNMTs) transiently modify C6 by 
attack of an active site cysteine.  Methylation results from the concerted addition of a methyl 
group derived from S-adenosylmethionine (SAM) to the C5 position [Figure 2] (7, 8).  The 
covalent intermediate breaks down to liberate the enzyme and generate genomic 5-
methylcytosine (mC).  Interestingly, in the absence of SAM, DNMTs can catalyze nonclassical 
reactions, such as deamination at C4 (9, 10) or the addition of aldehydes to C5 (11), raising 
intriguing questions about the relevance of these nonclassical functions in vivo.  The epigenetic 
impact of C5 methylation will be discussed later. 
3	  
	  
	  
Figure 2: Mechanism of DNA methylation.  DNA methyltransferases catalyze transfer of a 
methyl group (shown in magenta) from S-adenosylmethionine (SAM) to the C5 position of 
cytosine, generating 5-methylcytosine (mC) and S-adenosylhomocysteine. 	  
Previously underappreciated, oxidative modifications of mC are also possible.  In 
mammals, oxidation of mC is carried out by the TET family enzymes, which belong to the 
Fe(II)/α-ketoglutarate-dependent oxygenase family that includes histone demethylases and the 
DNA damage repair enzyme AlkB [Figure 3] (12, 13).  Rao and colleagues initially discovered the 
TET family based on homology to a trypanosome enzyme known to catalyze oxidation of the 
exocyclic methyl group of thymine. Initially, TETs were shown to oxidize mC to 5-
hydroxymethylcytosine (hmC) (12).  However, more recent studies have revealed that TETs can 
catalyze iterative oxidation of mC. The products of iterative oxidation, 5-formylcytosine (fC) and 5-
carboxylcytosine (caC), are stably detectable intermediates in genomic DNA from embryonic 
stem (ES) cells (14, 15).  In total, the TET enzymes have provided a stable of new chemical 
handles whose impacts on transcriptional regulation and demethylation we will examine later. 
 
Figure 3: Mechanism of DNA Oxidation.  TET oxidases catalyze Fe(II)-dependent oxidation of 
mC to 5-hydroxymethylcytosine (hmC), with molecular oxygen serving as donor for oxidation 
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(shown in magenta), with the second oxygen atom transferred to succinate.  hmC may be further 
oxidized to 5-formylcytosine (fC) and 5-carboxylcytosine (caC).    
 
  The C4 position of cytosine is relatively protected while engaged in Watson-Crick 
pairing, but in the context of single-stranded DNA, it becomes an important site for deamination 
by AID/APOBEC family enzymes [Figure 4] (16).  The mechanism of deamination involves 
activation of a zinc bound water for nucleophilic attack at C4 and generation of a tetrahedral 
intermediate.  An active site glutamate promotes deamination of C4 and the conversion of 
cytosine analogues into uridine analogues (17).  In addition to deamination of unmodified 
cytosine, some studies have suggested that mC deamination can generate thymine (16, 18).  
However, the evidence surrounding this possibility is conflicting (19), and the full spectrum of 
AID/APOBEC activity against various cytosine analogues has not yet been clarified.  These 
questions and their impact on diversity will be explored later.  The distinction between genomic 
malleability and instability is subtle.  Deamination of cytosine and 5-methylcytosine may cause 
transition mutations; deamination is therefore a very relevant threat to genome stability. In 
response, sophisticated DNA repair machinery has evolved to ensure the integrity of DNA (18), 
namely, base excision repair enzymes (BER) and mismatch repair (MMR) enzymes. Interestingly, 
many of these ‘repair’ enzymes are exploited to support cytosine’ s role in generating diversity. 
	  
Figure 4: Mechanism of DNA Deamination.  AID/APOBEC deaminases catalyze deamination 
of cytosine to uracil through nucleophilic attack of a water molecule at the C4 position.  
Nucleophilic water molecule is indicated in magenta.	  
1.1.3 Cytosine Modification Activates DNA Repair Pathways 
Several BER enzymes are worthy of particular attention, with uracil DNA glycosylase 
(UDG) standing out for its robust ability to excise uracil from DNA [Figure 5].  Given the need to 
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exclude uracil, UDG conspires with deoxyuridine triphosphatase to ensure the presence of 
thymine over uracil in DNA (20, 21).  The only naturally occurring lesion that is efficiently targeted 
by UDG is uracil, though unnatural lesions such as 5-fluorouracil are also processed (22).  
Stringent selectivity against thymine occurs by enzymatic discrimination against bulky C5 
substituents, while specific hydrogen bonding to a key active site asparagine residue selects 
uracil over cytosine (23-25).  As we will note later, in addition to its principal role in promoting 
DNA fidelity, UDG is exploited to generate diversity when uracil is purposefully introduced into the 
genome.  A second key DNA repair enzyme is thymine DNA glycosylase (TDG), which targets 
T:G mispairs that arise from deamination of mC in CpG motifs.  Spontaneous deamination of mC 
produces thymine, which unlike uracil is naturally occurring in DNA and therefore more 
challenging to recognize as a lesion (21).  Furthermore, mC is an order of magnitude more prone 
to spontaneous deamination than cytosine (26, 27).  These factors likely contribute to the 
increased mutation frequency at methylated CpG sequences in cancerous cells (28).  A challenge 
lies in editing these resulting T:G mispairs: to repair this mutation without error, repair machinery 
much first recognize the mispair and then specifically excise thymine and not guanine. TDG and 
the enzyme MDB4 are both capable of this activity. Mice deficient in MBD4 do exhibit increased C 
to T mutations and tumorigenesis (29, 30), although the embryonic lethality of the TDG knockout, 
and not MBD4, suggests additional important roles for TDG (31, 32). 
	  
Figure 5: Mechanism of base excision.  DNA glycosylases, including UDG and TDG, catalyze 
base excision of cytosine and uracil base analogs.  Nucleophilic addition of water (shown in 
magenta) cleaves the N-glycosidic bond between base and sugar, resulting in generation of an 
abasic site and liberation of the free pyrimidine base.	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Several features distinguish TDG from UDG.  First, the enzyme actively recognizes the 
opposite strand G and a neighboring G, biasing activity toward T:G mismatches within CpG 
motifs (33).  Second, the stability of the pyrimidine N-glycosidic bond, not simply the presence or 
absence of C5 substituents, impacts substrate preferences.  In fact, TDG can cleave not only 
uracil-related nucleobases but also modified cytosine residues whose N-glycosidic bond is 
destabilized, such as 5-fluorocytosine (34).  This unique mechanism of substrate recognition went 
largely underappreciated until the discovered that the epigenetic bases fC and caC are substrates 
as well.   Lastly, UDG knockout mice are viable and fertile, whereas the TDG knockout mice are 
embryonic lethal, standing as the only known DNA glycosylase with such a phenotype (31, 32, 
35). 
An additional BER enzyme that may contribute to diversity is single-stranded 
monofunctional DNA glycosylase (SMUG).  This misnomer belies the fact that SMUG 
preferentially acts on double-stranded DNA and that it targets several uracil-related lesions (36).  
A water molecule adjacent to the C5 position provides a mechanism for selectively processing 
uracil.  Intriguingly, a C5-hydroxymethyl substituent can replace this active-site water (37), 
making 5-hydroxymethyluracil (hmU) a good substrate, with potential relevance to epigenetic 
reprogramming (38). 
1.2 Mammalian Cytosine Modification Pathways	  
1.2.1 Cytosine Methylation Contributes to Development and Oncogenesis	  
  Cytosine methylation is known to modulate gene expression and cellular identity.  Its 
significance is attested by the embryonic lethal phenotype of the genetic depletion of DNA 
methyltransferases.  Although this modification has been well studied, in the context of 
considering the role of cytosine in modulating genomic potential, certain aspects of this topic are 
worthy of reconsideration. 
Cytosine methylation upstream of transcriptional start sites is a stable chemical 
modification associated with transcriptional repression in eukaryotic organisms (39).  Cytosine 
methylation occurs predominantly in the context of CpG motifs.  CpG motifs are 
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disproportionately underrepresented in the human genome, occurring four times less frequently 
than would be predicted by a random distribution.  Further, these motifs are highly enriched in 
specific regions designated as CpG islands (40).  The non-random distribution of potential CpG 
methylation sites bolsters the notion that cytosine serves an important diversity-generating 
function.  CpG methylation alters transcriptional repression through multiple pathways, rooted in 
biophysical and biochemical changes that take place in the overall DNA structure (41).  DNA 
methylation increases the melting temperature of duplex DNA, potentially decreasing promoter 
accessibility to RNA polymerase (42).  Further, the C5 methyl group projects into the major 
groove of duplex DNA, providing a biochemical handle that can be interrogated by DNA binding 
proteins. The impact of methylation can be direct, abrogating binding of numerous transcription 
factors as one means to decrease gene expression (39).  Alternatively, transcriptional repression 
can be indirectly affected, via methyl-DNA binding proteins that subsequently recruit histone 
modifying enzymes (43).   
Functionally, cytosine methylation can restrain the inappropriate expression of genes; 
thus the identity and location of the modified cytosine shapes cellular function.  During 
embryogenesis, methylation silences the transcription of lineage-specific genes to prevent 
aberrant protein expression that may interfere with differentiation and proper development (3).  
Upon differentiation, pluripotency genes are similarly methylated to ensure the adoption of a 
lineage-specific cell fate (4).  Methylation also regulates imprinting, the parental-specific 
regulation of gene expression of endogenous genes as well as autosomal transgenes (44).  This 
process ensures monoallelic gene expression, which maintains appropriate gene dosing during 
development.  Defective imprinting results in a panoply of genetic diseases that feature profound 
developmental deficits.    
In addition to its importance in embryogenesis, dysregulation of DNA methylation is 
associated with oncogenesis.  Aberrant methylation may result in inappropriate silencing of tumor 
suppressor genes (45, 46).  Globally, altered methylation patterns are seen in tumors of several 
organ systems, including colon, lung, breast, thyroid and kidney (47).  These observations have 
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led to the proposal that DNA methylation maintains epigenetic stability that prevents variability in 
gene expression resulting in pre-cancerous and cancerous states.  In tumors where the burden of 
mutagenesis is low, such as AML (48), the loss of epigenetic stability may be a driver of 
oncogenesis As a whole, the chemical modification of cytosine, as governed by DNMTs, plays an 
essential role in dictating the phenotypic outcome of the genome in a given cell. 
1.2.2 DNA demethylation and regeneration of unmodified cytosine 
Just as cytosine methylation is critical for repression of gene expression, the reverse of 
this process, the removal of the methyl group, allows cells to newly express previously repressed 
genes or to recover their totipotent potential. Until recently, this process of cytosine demethylation 
was thought to be a passive process in which replication without the action of maintenance 
DNMTs dilutes mC from DNA. However, mounting evidence suggests that replication-
independent, “active” (enzymatic) demethylation also occurs, globally in totipotent cells (49, 50) 
and also in a locus specific fashion within somatic cells (51-55).  Active cytosine demethylation, 
therefore, has now been recognized as a crucial molecular process and is yet another example of 
the role of cytosine in modulating genomic potential.  Cytosine demethylation is relevant even at 
the earliest stages of mammalian development.  Upon penetrating the zona pelucida, the paternal 
pronucleus is rapidly demethylated (49).  Remarkably, the maternal pronucleus sits in the same 
cytoplasm and is exclusively demethylated via passive demethylation; the mechanism for such 
asymmetric demethylation remains unclear, but it thought to be mediated by association with the 
factor Stella (56). Beyond the zygote and blastula stages, a subset of cells is induced to travel to 
the gonadal ridge and become primordial germ cells (PGCs). Although PGC genomes are widely 
methylated at the time they are designated, they are globally demethylated by the time they arrive 
at the gonadal ridge several days later (57).  Given that maintenance DNMTs are expressed in 
PGCs, such global demethylation is assumed to require active demethylation. 
Several examples of locus-specific active demethylation suggest that this process is 
likewise important in the normal functioning of somatic cells. Fast methylation and demethylation 
cycling at the estrogen receptor promoter provide a notable example of locus-specific active 
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demethylation (52, 53).  Other studies in CD8+ T-cells illustrated that expression of IL-2 can be 
induced via replication-independent demethylation, suggesting a role for active demethylation in 
sustained immune responses (54).  Finally, even neural plasticity is impacted by active 
demethylation as evidenced by changes at the promoter for brain-derived neurotrophic factor 
(38). 
1.2.3 Oxidation of Methylcytosine Also Contributes to Development and Oncogenesis 
An additional layer of complexity was revealed by the discovery that mC may be oxidized 
to hmC. This modification was first identified in bacteriophage genomes as a strategy to evade 
bacterial restriction endonucleases (58).  The epigenetic landscape changed significantly when 
Rao and colleagues discovered the TET family of mC oxidase enzymes in mammals and the 
Heintz group concurrently reported the presence of hmC in the mouse brain (12, 59).  Further 
studies have demonstrated that hmC is found throughout the body, albeit at a low frequency. In 
tissues where hmC is most enriched, the base comprises no more than 1% of all cytosines (60, 
61).  Much of the focus on hmC has surrounded its presence in embryonic tissues and stem cells. 
Indeed, several groups have described the presence of hmC in the paternal pronucleus of the 
fertilized egg (62, 63), and chromatin immunoprecipitation studies have shown an association 
between hmC and bivalent H3K4-H3K27 histone trimethylation, an epigenetic hallmark of key 
embryonic genes (64, 65).  Though it is known that hmC levels in ES cells decrease during 
differentiation (59, 66-68), the modulation of hmC in adult tissues remains poorly understood. 
Within the genome, much like mC, hmC localizes upstream of transcription start sites, but it may 
also be found in intragenic bodies (65, 66). 
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Figure 6: Cytosine methylation and hydroxymethylation regulate transcription.  Whereas 
methylation typically represses gene expression, the epigenetic role of hydroxymethylation is still 
being explored.  Hydroxymethylation is thought to play both activating and inactivating roles in 
gene expression.	  
Given that the discovery of eukaryotic hmC was so recent, work is ongoing to describe its 
functional significance. Initial reports implicated hmC as a “poised” intermediate on the path to 
cytosine demethylation, a topic to be tackled in Chapter 4 (38, 69, 70).  However, the current data 
also strongly suggest that hmC, as a stable modification of cytosine, has its own epigenetic 
regulatory role with respect to modulating the genome [Figure 6]. From a biophysical perspective, 
hmC has been shown to partially alleviate the energetic barrier for melting mC-containing duplex 
DNA; Tm values are similar to those of free cytosine (42, 71).  However, hmC appears enriched 
in the promoter region of a gene, a pattern that often correlates with transcriptional repression 
(65).  Some DNA binding proteins like MeCP2 distinguish between mC and hmC, whereas 
others, such as the maintenance methyltransferase factor Uhrf1, will bind both hmC and mC (72).  
This implies that the information encoded by hmC may dictate chromatin structure via 
mechanisms distinct from mC. This notion is strengthened by the observations that TET1 
associates with Sin3A repressor complexes and histone deacetylases (73), and that all three 
TETs associate with O-linked β-N-acetylglucosamine transferase to mediate serine/threonine 
glycosylation of as-yet poorly described targets (74, 75).  At this time, early reports indicate that 
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hmC may be a stable DNA modification that, like its precursor mC, causes transcriptional 
repression.  Currently, it is unclear what impact intragenic hmC exerts; the base may disrupt 
methyl-binding domain interactions that remodel euchromatin to heterochromatin (76) or may 
activate transcription at alternative promoters (3).  Clarifying these proposed epigenetic roles of 
hmC, in addition to its putative role in demethylation, is an important challenge ahead. 
Characterization of fC and caC within the genome remain an area of emerging study.  
The limited abundance of these bases—approximately 10% of hmC levels, and 0.1% of overall 
cytosine levels—raises questions about their physiologic relevance and poses a challenge 
towards their accurate detection (15, 77, 78).  Currently, the strongest evidence in favor of their 
physiologic significance is that TDG is capable of fC and caC excision (15, 33), linking two 
proposed players in DNA demethylation in a novel and plausible manner.  This will be discussed 
further in chapter 4.  Moreover, techniques have recently been developed that permit the 
sequencing of these higher oxidation products with single base resolution, leading to the profiling 
of fC and enhancer elements and other distal regulatory regions (79, 80).	   
A gathering body of evidence supports important roles for the various TET isoforms in 
physiological niches where DNA demethylation is thought to be relevant.  Though much remains 
to be resolved, genetic deletion leads to perturbed demethylation of paternal pronuclei and 
embryonic demise in the case of TET3 (81), dysregulation of hematopoiesis in the case of TET2 
(82, 83), and diminished embryonic growth and cognitive impairment of viable offspring in the 
case TET1 (84-86).  These genetic findings couple with biochemical studies to make a case for 
the TET enzymes as major regulators of DNA demethylation. 
1.2.4 Cytosine Deamination Contributes to Adaptive and Innate Immunity 
  The numerous DNA cytosine-modifying enzymes each play important physiologic roles 
in generating genomic variety. On its face, cytosine deamination is antagonistic to the primary 
function of DNA as a stable reservoir of information.  However, when the process is highly 
targeted and controlled, purposeful deamination is used to yield beneficial mutations. 
The foremost example of deamination as a means to diversity is demonstrated by the 
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adaptive immune system (5, 17).  The mature antibody pool is a collection of heterogeneous 
antigen-binding molecules produced through multiple diversity-generating mechanisms. 
Programmed recombination of gene segments (VDJ recombination) provides the initial repertoire 
of B-cells, each encoding a different surface-bound IgM molecule. However, this diversity is 
insufficient to yield the high-affinity interactions needed for robust immune responses. In a key 
transformation that occurs after exposure to antigen, B cells in the germinal center are matured 
by two genome-altering processes: somatic hypermutation (SHM) and class switch recombination 
(CSR) [Figure 7]. In SHM, antibodies evolve from low-affinity to high-affinity by the introduction of 
mutations into their antigen-recognition loops at a rate 10^6 times that of spontaneous mutation. 
In CSR, the effector domain of the heavy chain is switched from IgM to yield the alternate 
isotypes IgA, IgE, or IgG. 
	  
Figure 7: Cytosine deamination in antibody maturation.  Cytosine deamination in the 
immunoglobulin locus generates uracil.  Error-prone repair of uracil in VDJ regions results in 
localized mutations that increase antibody affinity in somatic hypermutation.  Clustering of uracil 
bases in switch regions leads to double-stranded DNA breaks that are recombined, ultimately 
altering the antibody isotype. 
 
The DNA-modifying enzyme activation-induced deaminase (AID) mutates key cytosines 
in the Ig locus to initiate the molecular events that lead to SHM or CSR  (5, 17).  AID expression 
is largely B-cell specific and restricted to germinal centers, the site of SHM and CSR (87).  In 
SHM, AID introduces uracil into Ig locus DNA (88).  The uracil lesions are then subjected to repair 
pathways involving UDG, mismatch repair enzymes, and low-fidelity, rather than high-fidelity, 
DNA polymerases, like DNA pol η (89).  The DNA “repair” pathway is therefore co-opted to 
promote error-prone repair, resulting in hypermutation of antibody molecules.  In CSR, AID 
targets cytosine residues that are on opposite strands in the switch regions immediately upstream 
!
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of the various heavy chain loci encoding IgM, IgG, IgE, or IgA (90).  Clustered deamination on 
both DNA strands leads to double-stranded DNA breaks, which are resolved by recombination to 
result in isotype switching. 
AID’s catalytic activity is enhanced by interactions with two protein-binding partners that 
mediate targeting to the actively transcribed immunoglobulin genes.  To facilitate AID’s 
interactions with regions of single-stranded DNA, RPA binds to single-stranded DNA on the non-
template strand during transcription and recruits phosphorylated AID (91, 92).  These interactions 
with the separated strands of actively transcribed DNA are further facilitated by Spt5, which 
promotes AID binding to RNA polymerase II and sites of active transcription (93).  Both of these 
factors augment AID’s deaminase activity within the cell, manifest through increased rates of 
somatic hypermutation and class-switch recombination. 
Given the fine line between genomic malleability and instability, an important factor in 
deamination by AID is appropriate targeting (94, 95).  Hyperactive AID is associated with 
common oncogenic translocations as well as leukemic progression and drug resistance in chronic 
myeloid leukemia (96, 97).  Chromosomal translocations have been documented between IgH 
and every other chromosome within the cell (98, 99).  AID is known to act throughout the genome 
but preferentially acts at the Ig locus, with a balance between deamination and repair determining 
function (100).  Troublingly, the Myc oncogene is one of the most-frequently deaminated off-
target genes.  The factors that predominantly restrain AID’s activity to the immunoglobulin locus 
remain poorly understood, but have a critical bearing for the mutagenic potential of AID.   
Though AID-catalyzed SHM and CSR are exemplars of purposeful cytosine deamination, 
they are not the only examples.  AID is closely related to APOBEC enzymes, best known for their 
roles in restricting retroviruses such as HIV (101).  One family member, APOBEC3G (A3G), acts 
as a kind of Trojan horse against HIV: it can be integrated into budding HIV virions and, upon 
infection of a new cell, works to damage the HIV genome.  A3G deaminates the negative-
stranded viral cDNA generated by reverse transcription, introducing a high frequency of uracil that 
impairs viral integration and disrupts essential viral proteins.  As a counterattack measure, 
14	  
	  
lentiviral pathogens express Vif, a small accessory protein that targets A3G for ubiquitination and 
degradation (102).  Intriguingly, even in the presence of Vif, A3G is occasionally packaged at low 
levels into HIV. This observation raises the possibility that low levels of A3G mutagenesis may in 
fact confer a survival advantage to HIV by yielding viral variants that can escape immune 
pressure or antiviral challenges (103).  Indeed, sublethal mutagenesis and robust acquisition of 
resistance to antivirals has been demonstrated when HIV was cultured in the presence of cellular 
A3G (104-106).  Thus, just as our immune system exploits cytosine deamination to generate 
variety via AID, viral pathogens, though primarily antagonized by A3G, also are able to control the 
deaminase to access beneficial genomic variety. 
1.3 AID/APOBEC Family of Cytidine Deaminases 
1.3.1 Members of the AID/APOBEC Family 
 The actions of AID and A3G indicate the most prominent roles for cytidine deamination, 
but these enzymes belong to a larger family of cytidine deaminases that are responsible for all 
known roles of cytosine deamination in DNA.  Named for the founding member Apolipoprotein B 
mRNA Editing Catalytic Polypeptide 1, the entire AID/APOBEC family consists of four members: 
AID and APOBEC 1, 2, and 3 [Figure 8].  There are preliminary reports of additional APOBEC 
family members—APOBEC 4 and 5—but these remain largely putative as they rely heavily on 
computational homology searches within the genome that have not been properly cloned, 
expressed, and characterized (107). 
	  
Figure 8: AID/APOBEC family members.  Listed are a schematic detailing number of 
deaminase domains, canonical function, physiologic substrates, and preferred sequence targets.	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APOBEC2 CDD
APOBEC3 CDD CDD
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15	  
	  
 The AID/APOBEC family originated with the discovery of APOBEC1 for its role in editing 
the mRNA transcripts of apolipoprotein B (108, 109).  Specifically, APOBEC1 deaminates 
cytosine to uracil at position 6666, introducing a missense mutation ultimately resulting in a 
truncated form of apolipoprotein B and regulating lipid metabolism.  Other mRNA targets have 
been identified as well, including the targets in the brain and small intestine (110).  APOBEC1’s 
RNA deaminase activity requires the assistance of a co-factor, APOBEC1 Complementarity 
Factor (ACF) (111, 112).  ACF seems to play a critical role in anchoring APOBEC1 to AU-rich 
target sequences in mRNA transcripts, but precise interactions between the two remain poorly 
understood.  In addition to APOBEC1’s role in RNA editing, studies have proposed novel roles in 
retroviral restriction, memory formation, and susceptibility to testicular germ cell tumors (38, 113).  
However, these novel functions remain preliminary and require additional experimental validation. 
 Within the AID/APOBEC family, APOBEC1 is unique in that it targets RNA instead of 
DNA (114).  Given that APOBEC1 was the first discovered member of the AID/APOBEC family, it 
was naturally assumed that subsequent family members might be RNA deaminases as well (87).  
Further biochemical characterization of APOBEC1 has demonstrated that the enzyme possesses 
DNA deaminase in vitro, providing an indication that DNA deamination may be a hallmark of the 
AID/APOBEC family (115-117).  Notably, a recent report utilizing comparative genomic sequence 
analysis has suggested that DNA deamination is APOBEC1’s ancestral function, with RNA 
deaminase activity emerging only recently (118). 
 Much less is known about the homolog APOBEC2.  Although the crystal structure of 
APOBEC2 has been described, no known catalytic activity has been attributed to the enzyme 
(119).  APOBEC2 expression is restricted to cardiac and skeletal muscle lineages, and its 
deficiency in mice appears to confer a slight deficit in muscle regeneration (120).  Curiously, while 
there appears to be little role for APOBEC2 in mammals, a different story emerges in zebrafish 
(121).  In this model organism, APOBEC2 not only retains catalytic DNA deaminase activity, but 
has also been linked to epigenetic regulation and retroviral restriction.  However, given that 
zebrafish are a distant ancestor from mammals, they have not evolved the full family of 
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APOBECs (122), and it is therefore possible that zebrafish APOBEC2 has retained certain 
functions that have been lost in the mammalian lineage through functional redundancy with newer 
homologs. 
 APOBEC3 represents the largest subfamily amongst the AID/APOBECs.  While many 
species only have a single APOBEC3 representative (such as mouse and rat), a series of 
chromosomal duplications and expansions have left certain vertebrates (primates) with up to 11 
APOBEC3 family members [Figure 9] (122).  Seminal studies on human APOBEC3G (A3G) 
demonstrated an ability to restrict HIV infection (113, 123), suggesting a possible role for the 
APOBEC3 family as a viral restriction factor.  Subsequent studies have confirmed such a role.  
Within the human APOBEC3 family, additional family members are capable of HIV restriction 
(124-126).  APOBEC3 family members from other species are similarly capable of retroviral 
restriction.  Other classes of viruses, including parvoviruses, adeno-associated viruses and 
retrotransposons, are subject to restriction as well (127, 128).  APOBEC3 family enzymes are 
predominantly expressed in myeloid and lymphoid lineages and readily induced by several 
cytokine-signaling pathways (122).   
	  
Figure 9: APOBEC3 locus expansion from the mouse genome to the human genome.  
Whereas mice have a single APOBEC3 family member, humans have 8 well-characterized 
APOBEC3 family members. 
 Appropriate targeting seems to modulate APOBEC3 deaminase activity.  The role of Vif 
in regulation of A3G packaging into HIV has already been described (102).  For several family 
members, cellular localization plays an additional role in targeting deaminase activity.  For 
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homologs that target viral replication, expression in the cytoplasm localizes the restriction factor 
to the same cellular compartment as replicating virus (129).  Cytosolic localization may also be 
important for sequestering the DNA deaminase activity away from the nucleus, where 
deamination could promote mutation and oncogenesis (130).  Indeed, ectopic expression of A3B 
has been shown to contribute to mutagenesis in a subset of breast cancers (131-133), and when 
overexpressed, A3A’s robust deaminase activity is a potent activator of the DNA damage 
response and cell cycle arrest (134).    
1.3.2 Evolution of the AID/APOBEC family 
 The AID/APOBEC family of deaminases descends from a much larger deaminase 
superfamily with a broad array of targets (114).  In contrast to the AID/APOBECs, which 
deaminate cytosine in single-stranded DNA, some subclasses are able to deaminate adenosine 
instead of cytosine; further, some subclasses are capable of deaminating bases, nucleosides, 
nucleoside monophosphates, and nucleotides.  With regards to the AID/APOBEC deaminases, 
one family is prominent within the deaminase superfamily.  Of note are the tRNA adenosine 
deaminases, which are widely conserved across prokaryotes and eukaryotes.  These enzymes 
catalyze deamination of adenosine to inosine at the wobble position of tRNA anticodons so that 
degenerate codons are tolerated during translation.  Though the adenosine deaminases have a 
different substrate, they share important structural similarities with the AID/APOBEC family, which 
will be discussed later.  Both enzyme families target single stranded nucleic acids, and it is likely 
that the AID/APOBEC family evolved from the tRNA adenosine deaminases.  The AID/APOBEC 
family first emerged in bony fish, with AID and APOBEC2 as the founding members.  Of note, this 
discovery indicates that AID predates the origin of the immunogloblulin loci, its physiologic 
substrate in vertebrates.  Estimates date the emergence of the AID/APOBEC family prior to the 
divergence of bony fish from the tetrapod lineage, over 450 million years ago. 
 As the oldest members of the AID/APOBEC family, AID and APOBEC2 can be found the 
genomes of many vertebrates, ranging from fish to birds to mammals (122, 135).  The more 
recent emergence of APOBEC1 and APOBEC3 restricts these two family members to mammals.  
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Based on phylogenetic analysis of its synteny with AID in both mice and humans, APOBEC1 is 
thought to have arisen as a gene duplication of AID (135).  Similar intron-exon junctions between 
AID and APOBEC1 further support this notion.  APOBEC3 is also thought to have evolved from 
AID, though its evolutionary history appears more complex (135).  Unlike APOBEC1, APOBEC3 
has no syntenic relationship with AID.  Analysis of the mouse and rat genomes indicates a single 
APOBEC3 gene encoding an enzyme with two deaminase domains.  This contrasts with all other 
members of the AID/APOBEC family—AID, APOBEC1, APOBEC2—which contain only a single 
deaminase domain.  Thus, it is thought that the origins of APOBEC3 likely involve a duplication of 
ancestral AID.  The APOBEC3 expansion that occurred in primates likely resulted from a similar 
series of chromosomal expansion events, yielding an array of single-domain and double-domain 
deaminases. 
1.3.3 Catalytic Determinants of the AID/APOBEC Family 
 The core catalytic determinants of the AID/APOBEC family remain conserved with the 
larger deaminase superfamily.  AID/APOBEC deaminase domains are characterized by the 
deaminase consensus amino acid sequence contained within a single exon: HXE-X(23-28)-PCXXC 
[Figure 10] (122).  The histidine and cysteines coordinate the zinc atom within the active site of 
the deaminase domain that activates water for hydrolytic deamination of cytosine.  The active site 
glutamate plays a critical role in deamination by serving as a proton shuttle.  The glutamate first 
protonates the N3 position of cytosine, activating the C4 position for nucleophilic attack by the 
incoming water molecule.  Next, the glutamate assists the zinc atom in coordination of the 
incoming water molecule in the enzyme active site that attacks the C4 position.  The result of the 
nucleophilic addition of water at the C4 position is a tetrahedral intermediate that is resolved by 
the departure of ammonia as a leaving group, ultimately generating the uracil deamination 
product. 
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Figure 10: Catalytic determinants of AID/APOBEC deamination.  Cysteine and histidine 
residues coordinate zinc in enzyme active site.  Zinc and glutamate activate nucleophilic addition 
of water to C4 position, generating a tetrahedral intermediate that collapses to yield uracil.  
Schematic is taken from Harris et. al (122). 
 Considerably less is known about how cytosine is recognized for deamination.  At the 
level of the base, it is unknown how cytosine fits into the enzyme active site and is stabilized for 
deamination (136).  Of particular importance is the tolerance of the active site to modifications at 
the 5-position of the base.  Methylation and hydroxymethylation of cytosine have important roles 
in regulating the transcriptional activation of the cell.  AID and other APOBECs have been 
hypothesized to deaminate these modified cytosines, though their reactivity has not been properly 
evaluated.  This will be discussed further in Chapter 4.   
 Beyond the level of the base, it remains unknown how the entire nucleotide must position 
itself for deamination.  It has been hypothesized that AID may use a mechanism similar to DNA 
glycosylases, in which the enzyme scans along the DNA and flips target nucleotides out of 
stacking position in register with neighboring bases and into the enzyme active site (137).  A 
fundamental distinction is that these models typically describe the action of enzymes on double-
stranded DNA, unique from the single-stranded substrates of the AID/APOBEC family.  
Nevertheless, a model of DNA binding fit to the A3A structure supports such a hypothesis (138).  
Specifically, in this model the bases at the -2, -1 and +1 positions are stabilized by interactions 
with the exterior of the enzyme, while the target cytosine nucleotide is rotated ~180 degrees away 
from the neighboring bases and buried within the enzyme active site.  This model remains 
speculative, as there is currently no experimental evidence to support such a mode of 
recognition. 
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 Beyond the level of the target nucleotide, it is known that AID and the other APOBECs 
target cytosine for deamination with a sequence preference for the neighboring nucleotides.  For 
AID, deamination occurs preferentially at WRCY hotspot motifs (W= A or T, R= A or G, Y = C or 
T) (139, 140).  This consensus sequence is repeated throughout the switch regions in the 
immunoglobulin loci, and sequence specificity is thought to be an important component in 
properly targeting AID’s deaminase activity (90).  The other members of the APOBEC family 
similarly demonstrate sequence specificity (APOBEC1= AUC; A3G= CCC; A3A/B/F=YCA) (110, 
139).  The sequence preferences within this family are not absolute, as deamination occurs at 
disfavored coldspot motifs as well, albeit at rates that are diminished by ~10-fold (140).  These 
relaxed constraints on sequence specificity contrast with other DNA-modifying enzymes, which 
are significantly more selective.  For example, TDG excises thymine from T:G mismatches, but 
only if a G is present at the neighboring position (141).  If any other base is present at the +1 
position, TDG’s rate of excision drops by several orders of magnitude. 
 The basis for hotspot sequence targeting has been partially elucidated studying AID.  
Structural characterization of the APOBEC homolog A3G and the more distant adenosine 
deaminase relative TadA have revealed the presence of a loop at the exterior face of the enzyme, 
in close enough proximity to the active site that it may interact with the nucleotides neighboring 
the target cytosine (142-144).  Though the sequence of this loop is not conserved across the 
AID/APOBEC family, the length of the loop largely is, indicating the possibility of a conserved 
function (140).  Multiple groups have found that engraftment of donor loops from A3G into AID 
(AID-3GL) generates a chimeric deaminase that not only retains catalytic activity, but additionally 
possesses a sequence-specific deaminase activity skewed away from AID’s spectrum and 
towards that of A3G (140, 145, 146).  These results were consistent across biochemical studies 
with purified enzyme, as well as cellular studies in E. coli and DT40 B-cells.  The consistency of 
this finding has led to the reclassification of this loop as a ‘hotspot targeting loop’.  Curiously, 
while engraftment of donor loops from APOBEC3 family members into AID results in successful 
reprogramming of sequence-specific deaminase targeting, the inverse has not born true: 
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engraftment of the AID donor loop into several APOBEC3 family members has largely failed to 
reprogram sequence targeting. 
Curiously, studies of the hotspot targeting loop do not account for interactions with the 
phosphodiester backbone, and it remains poorly understood how AID and other APOBECs 
interact with their single-stranded DNA substrates.  It is well documented that AID has a high 
binding-affinity for single-stranded DNA, with dissociation constants reported as low as 1 nM (16, 
147).  Binding appears to occur independent of sequence context, as determined by ChIP-Seq as 
well as synthetic DNA substrates (148).  In addition to binding single-stranded DNA, AID also 
binds to artificial substrates with partial single-stranded character.  Specifically, binding 
interactions have been reported between AID and a ‘bubble’ substrate that consists of a largely 
double-stranded DNA substrate with a short patch of 5-9 nucleotides that are mismatched, so as 
to create local single-stranded character (137, 149).  It is believed that this artificial substrate 
better mimics the transcription bubbles that AID targets in the B-cell genome as compared to 
single-stranded DNA.  Demonstration of AID’s tighter binding to these bubble substrates leaves 
open the possibility that substrate binding may play an important role in AID/APOBEC 
deamination.   
AID’s binding characteristics largely describe the behavior of the rest of the APOBEC 
family.  Binding interactions have been well described for APOBEC1 and A3G, which also confirm 
low-nanomolar dissociation constants, indicative of high-affinity binding (115, 150).  A3A is the 
only exception to this observed pattern of high binding affinity (151, 152).  Whereas all other 
AID/APOBECs bind nucleic acids with dissociation constants in the low-nanomolar range, A3A 
appears to bind in the mid-micromolar range, indicating approximately 1000-fold impaired binding 
as compared to its APOBEC homologs.  The basis for this observation is poorly understood, 
particularly with regards to the kinetics of deamination.  Indeed, the many remaining questions 
regarding the catalytic mechanisms of AID and other APOBECs reflect limited insights available 
from structural studies on the family.   
1.3.4 Structural Characteristics of the AID/APOBEC Family 
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 The structural characteristics of the deaminase superfamily are well established, as the 
structures of several members have been solved by X-ray crystallography.  Initial results 
published on the deaminase superfamily homolog Cytidine Deaminase (CDA) demonstrate a 
beta-sheet consisting of five strands with mixed parallel-anti parallel character (153).  Both sides 
of the beta-sheet are flanked by alpha helices that link the beta-sheets in the primary structure of 
the enzyme.  The zinc-coordinating active site is contained on one face of the beta sheet by an 
alpha-beta-alpha motif.  This motif encompasses the third beta strand, embedded deeply within 
the core of the beta sheet.  These two structural characteristics are a hallmark of the family: 5 
stranded beta sheet that serves as the enzyme core and the alpha-beta-alpha motif that contains 
the zinc-coordinating active site.   
 Structural studies of APOBEC2 and APOBEC3 family members demonstrate the 
conserved structural characteristics of the larger deaminase superfamily (154).  APOBEC2 was 
the first member of the subfamily to be described structurally.  X-Ray crystallography 
demonstrated a tetramer, with one interface at the edge of the core beta pleated sheet, the other 
mediated by the loops that bridge the beta-pleated sheets and alpha helices at the exterior of the 
enzyme (119).  However, the relevance of this tetrameric oligomerization state has been 
questioned with regards to deamination, given that APOBEC2 lacks any catalytic activity.  Shortly 
after the publication of the APOBEC2 structure came the structural description of an APOBEC3 
family member, A3G.  A3G normally exists as a double-domained deaminase, with the C-
terminus being catalytically active and the N-terminus catalytically inactive.  Two independent 
reports—one using NMR, the other using X-Ray crystallography—published the structure of the 
C-terminus alone (142, 144).  These results verified the conserved structural determinants of the 
larger deaminase family: the core beta-pleated sheet and localization of the active site to the 
alpha-beta-alpha motif at the third beta strand [Figure 11].  However, these studies failed to report 
definitive mechanisms of A3G interaction with its DNA substrate, leaving open the pertinent 
question of how cytosine is specifically recognized by the enzyme for deamination. 
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Figure 11: Structural characteristics of AID/APOBEC deaminases.  Catalytic residues are 
retained within an alpha-beta-alpha repeat, shown in magenta.  Zinc-coordinating residues are 
shown in yellow, with zinc atom shown in white.  Catalytic glutamate, in blue, is partially obscured 
by the zinc atom.  The rest of the core beta sheet is indicated in orange. 
 The crystal structure of the distantly related adenosine deaminase TadA helped to 
elucidate the important structural characteristics of A3G, with regards to hotspot recognition.  The 
tRNA adenosine deaminases and AID/APOBEC deaminases are unique within their larger 
superfamily for their ability to bind single stranded nucleic acids.  The structure of RNA-bound 
TadA demonstrates interactions between the loop that bridges the fourth beta strand and fourth 
alpha helix (143).  Alignment with the structure of unbound A3G demonstrates the conserved 
structural determinants that comprise the hotspot targeting loop [Figure 12].  High resolution 
modeling based on the recently-solved structure of A3A further confirms the interaction between 
the hotspot targeting loop and DNA substrate, indicating the importance of this structure in the 
AID/APOBEC deamination reaction (138). 
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Figure 12: Structural basis for interaction between hotspot targeting loop and substrate 
nucleic acid.  Superimposed structure of unliganded A3G is shown in purple, with hotspot 
targeting loop indicated in red.  TadA target RNA is shown in beige, with target nucleotide 
indicated by asterisk.  Hotspot targeting loop is well positioned to interact with nucleotide at -1 
position (indicated in green).  Figure taken from Kohli et. al. (140) 
 Since the publication of the A3G structure, several additional APOBEC3 structures have 
been described, all unbound to nucleic acids (155, 156).  The absence of a bound nucleic acid 
target diminishes the impact of these studies, as they fail to reveal any new determinants of 
deamination.  Particularly in the absence of novel structural discoveries within the AID/APOBEC 
family, it is imperative to employ alternative methods to elucidate the characteristics of 
deamination.    
1.4 Thesis objectives 
 Continued research on AID has revealed a double-edged sword with regards to genomic 
instability.  On one hand, AID’s ability to catalyze cytosine deamination fosters immunologic 
diversity through somatic hypermutation and class-switch recombination, and AID’s deficiency 
results in immunodeficiency.  On the other hand, when AID’s catalytic activity is not properly 
restrained, aberrant cytosine deamination results in profound mutagenesis that can drive cancer 
development and progression.  While this delicate balance has been thoroughly demonstrated for 
AID, a similar picture is coming into view for other members of the APOBEC family, with 
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physiologic roles in innate immunity counterbalanced by off-target deamination contributing to 
oncogenesis.  With better characterization of the interface between enzyme and substrate will 
come further insights into the role of cytosine deamination in health and disease.  
 Further biochemical characterization of the AID/APOBEC deamination reaction can also 
provide insights into the novel, proposed roles for deaminases in DNA demethylation.  It has been 
proposed that AID and other APOBECs may deaminate mC or hmC.  These novel physiologic 
roles for deaminases have been implicated in embryogenesis, memory formation, and epigenetic 
stability.  However, the reactivity of AID/APOBECs against these modified cytosines remains a 
poorly profiled point of controversy. 
 Given the importance of elucidating these many questions, the work described within this 
thesis aims to clarify AID/APOBEC biology using biochemical approaches to characterize the 
nucleic acid determinants of deamination.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Protein Expression and Purification 
2.1.1 AID/APOBEC Expression and Purification 
Human AID (amino acids 1-181 or full-length) was cloned downstream of an N-terminal 
maltose binding protein in a pET41 expression plasmid.  Expression vectors containing the 
mouse APOBEC1, mouse APOBEC2, and mouse APOBEC3 genes downstream of an N-terminal 
maltose-binding protein (MBP) in pET41 (Novagen) were generously provided by Junjie Guo and 
Hongjun Song (Johns Hopkins University).   BL21-DE3 E. coli (Novagen) were transformed with 
expression constructs, grown to OD600 0.6, and protein expression was induced by addition of 1 
mM IPTG (Sigma).  Following induction, cells were transferred to 16 °C and incubated for 18 
hours before cultures were pelleted. 
Proteins were purified essentially as described previously (140).  Bacterial pellets were 
resuspended in 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol with EDTA-free protease 
inhibitors (Roche) and cells were lysed in a microfluidizer processor.  Following removal of the 
insoluble fraction of the cellular lysates by centrifugation, the soluble fraction was added to 
amylose resin (New England Biolabs) and incubated at 4 °C for one hour.  Resin was washed in 
a high salt buffer (750 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol), then low salt buffer (150 
mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol), and proteins were eluted with maltose-
containing elution buffer (10 mM maltose, 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol).  
Following elution, enzyme was dialyzed overnight at 4 °C in a storage buffer containing 75 mM 
NaCl, 50 mM Tris-HCl pH 7.5, 10% glycerol. 
For each sample, protein concentration was initially determined by collection of UV 
absorbance spectrum on a UV spectrophotometer (UV-1800, Shimadzu).  Absorbance at 280 nm 
was used to determine total protein concentration of bulk sample.  For each AID/APOBEC family 
member, a significant peak was also observed at 260 nm, indicating the presence of co-purifying 
nucleic acids.  To assess the purity of each protein preparation, SDS-PAGE was performed 
[Figure 13].  The presence of multiple co-purifying bands at unexpected molecular weights 
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indicates partial purity of each purified enzyme sample.  Co-purifying contaminants likely 
represent truncation products of deaminase translation, as well as endogenous, E. coli proteins 
that bind nucleic acids. 
 
Figure 13: SDS-PAGE of partially purified AID/APOBEC family members. The mouse genes 
encoding mAPOBEC1 (mA1), mAPOBEC2 (mA2), and mAPOBEC3 (mA3) and the human genes 
encoding full-length human AID (hAID) and its hyperactive C-terminally truncated variant (hAID-
ΔC) were expressed as N-terminal fusions to maltose binding protein (MBP).  Binding to amylose 
resin yielded partially purified enzymes. Shown is a Coomassie-stained gel of the proteins, with 
the major contaminants representing MBP and truncation products.  
 The presence of a high 260 nm absorbance peak bears particular relevance for 
biochemical studies on purified enzyme.  Given the high binding affinity for nucleic acids, purified 
AID (and other APOBECs) are predominantly bound to nucleic acids—both RNA and DNA—that 
originate from the cellular source of protein expression.  For in vitro reactions, these bound 
nucleic acids act as a competitive inhibitor of deamination, and their removal increases enzymatic 
deaminase activity.  RNA predominates as the most abundantly bound nucleic acid species, and 
pre-treatment with RNase greatly improves the enzymatic activity of purified AID.   
2.1.2 MBP Expression and Purification 
 MBP control was generated via cassette mutagenesis by introducing a stop codon at the 
first codon of AID in the MBP-AID construct [Table 1].  The construct was transformed into BL21-
DE3 E. coli as described for AID/APOBEC purification; however, once protein expression was 
70 kDa
55 kDa
35 kDa
100 kDa
130 kDa
mAPOBEC1 A1MBP
mAPOBEC2 A2MBP
hAID AIDMBP
hAID-?C AIDMBP
mAPOBEC3 A3 A3MBP
71.5 kDa
69.6 kDa
97.8 kDa
67.9 kDa
66.0 kDa
Molecular
WeightMB
P-
mA
1
MB
P-
mA
2
MB
P-
mA
3
MB
P-
hA
ID
-?
C
MB
P-
hA
ID
mA1
mA2
mA3
hAID
hAID
-?C
28	  
	  
induced, cultures were maintained for only two hours at 37 ºC before pelleting.  Protein 
purification proceeded as described for AID/APOBECs, with the following exceptions: cells were 
lysed by sonication (Sonicator 3000, Misonix), and the wash with the high-salt buffer was omitted. 
 Protein concentration was assessed by UV absorbance at 280 nm.  As a contrast to 
AID/APOBECs, no absorbance at 260 nm was detected, indicating the absence of co-purifying 
nucleic acids.  SDS-PAGE was used to determine protein purity [Figure 14].  The absence of co-
purifying bands indicates the high degree of purity of the MBP control protein.  These impurities 
contrast with the MBP-tagged deaminase enzyme preparations, indicating that both nucleic acid 
binding and co-purifying contaminants are likely attributed to the presence of the deaminases. 
 
Figure 14: SDS-PAGE of MBP control protein.  Shown is a Coomassie-stained gel of all 
fractions from purification of MBP control protein.  Purified protein is shown in the two lanes 
furthest to the right, as both diluted and concentrated samples.  The absence of co-purifying 
bands demonstrates purity of the protein preparation.  
2.2 Synthesis of chimeric oligonucleotide substrates 
All oligonucleotides were synthesized using standard phosphoramidite chemistry.  The 
majority of substrates were synthesized using ABI 394 Synthesizer (Applied Biosystems), and the 
remainder were synthesized either by Integrated DNA Technologies or the University of Calgary 
DNA Synthesis Core Facility [Table 1].  Phosphoramidite building blocks and reagents were 
obtained from Glen Research or Metkinen Chemistry and used according to the manufacturer’s 
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recommendations.  Following synthesis, oligonucleotides were deprotected and purified using 
Glen-Pak DMT-ON columns, according to the manufacturer’s recommendations.   
To confirm complete deprotection, purified oligonucleotides were analyzed by MALDI-
TOF mass spectrometry.  In brief, oligonucleotides were concentrated using ZipTips containing 
C18 resin (EMD Millipore) and resuspended in a matrix containing 2-picolinic acid and ammonium 
citrate.  Samples were analyzed on a Microflex mass spectometer (Bruker), using a negative 
voltage polarity for detection.  All measured masses were within 5 mass units of the predicted 
molecular weight [Table 1].  Oligonucleotides synthesized by Integrated DNA Technologies were 
analyzed by MALDI TOF or ESI as part of the manufacturer’s internal quality control.  All 
substrates were further purified PAGE purified to remove residual truncation products.   
The majority of oligonucleotides substrates was synthesized on 6-Fluorescein (FAM) 
CPG columns and therefore contain a 3'-FAM label.  For the minority of substrates that were 
synthesized without 3'-FAM, fluorescent labeling was necessary to permit visualization.  
Following synthesis, these oligonucleotides were enzymatically 3'-end labeled with ddUTP-12-
FAM (Enzo Life Sciences) by incubation with Terminal Transferase (New England Biolabs) and 
purified using QIAquick Nucleotide Removal Kit (Qiagen). 
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Table 1: Oligonucleotides 
  Mass Spec Mass Spec 
Synthesized 
by 
Substrate 
Name Sequence Predicted Detected  
DNA 
Chimeric 
Substrates 
    
D-dC 5'- AGA ATT AAG TTA AGdC TAG TTA AGT TAT -3' 8360.5 8359.1 IDT 
D-dU 5'- AGA ATT AAG TTA AGdU TAG TTA AGT TAT -3' 8361.5 8360.5 IDT 
D-rC 5'- AGA ATT AAG TTA AGrC TAG TTA AGT TAT -3' 8376.5 8376.6 IDT 
D-rU 5'- AGA ATT AAG TTA AGrU TAG TTA AGT TAT -3' 8377.5 8377.3 IDT 
D-frC 5'- AGA ATT AAG TTA AGfrC TAG TTA AGT TAT -3' 8378.5 8378.9 IDT 
D-frU 5'- AGA ATT AAG TTA AGfrU TAG TTA AGT TAT -3' 8379.5 8378.6 IDT 
D-aC 5'- AGA ATT AAG TTA AGaC TAG TTA AGT TAT -3' 8376.5 8374.9 Calgary Seq. Facility 
D-aU 5'- AGA ATT AAG TTA AGaU TAG TTA AGT TAT -3' 8377.5 8376.3 Calgary Seq. Facility 
D-faC 5'- AGA ATT AAG TTA AGfaC TAG TTA AGT TAT -3' 8378.5 8377.6 Authors 
D-faU 5'- AGA ATT AAG TTA AGfaU TAG TTA AGT TAT -3' 8379.5 8378.0 Authors 
A1-D-dC 5'- AGA ATT AAG TTA TTdC TAG TTA AGT TAT -3' 8326.5 8326.0 IDT 
A1-D-dU 5'- AGA ATT AAG TTA TTdU TAG TTA AGT TAT -3' 8327.5 8327.1 IDT 
A1-D-rC 5'- AGA ATT AAG TTA TTrC TAG TTA AGT TAT -3' 8342.5 8342.5 IDT 
A1-D-rU 5'- AGA ATT AAG TTA TTrU TAG TTA AGT TAT -3' 8343.5 8344.1 IDT 
A1-D-frC 5'- AGA ATT AAG TTA TTfrC TAG TTA AGT TAT -3' 8344.5 8345.9 IDT 
A1-D-frU 5'- AGA ATT AAG TTA TTfrU TAG TTA AGT TAT -3' 8345.5 8347.4 IDT 
D-TAdC 5'- AGA ATT AAG TTA TAdC TAG TTA AGT TAT -3' 8335.5 8335.2 IDT 
D-TAdU 5'- AGA ATT AAG TTA TAdU TAG TTA AGT TAT -3' 8336.5 8336.9 IDT 
D-TArC 5'- AGA ATT AAG TTA TArC TAG TTA AGT TAT -3' 8351.5 8351.3 IDT 
D-GTdC 5'- AGA ATT AAG TTA GTdC TAG TTA AGT TAT -3' 8296.5 8295.5 IDT 
D-GTdU 5'- AGA ATT AAG TTA GTdU TAG TTA AGT TAT -3' 8297.5 8297.1 IDT 
D-GTrC 5'- AGA ATT AAG TTA GTrC TAG TTA AGT TAT -3' 8312.5 8312.2 IDT 
Switch-dC 5'- ATG AGC TGG GAA TGA GCT GAG dCTA GGC TGG AAT AGG CTG GGC TGG -3' 14127.2 14128.1 IDT 
Switch-dU 5'- ATG AGC TGG GAA TGA GCT GAG dUTA GGC TGG AAT AGG CTG GGC TGG -3' 14128.1 14127.6 IDT 
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Switch-rC 5'- ATG AGC TGG GAA TGA GCT GAG rCTA GGC TGG AAT AGG CTG GGC TGG -3' 14143.2 14142.1 IDT 
2'-F-RNA 
Chimeric 
Substrates 
    
D-control C 5'- GGA AGG AAG UUG UGC GAG UGG GGU GGU AGG (6-FAM) -3' 10013.5 10014.0 Author 
D-control U 5'- GGA AGG AAG UUG UGU GAG UGG GGU GGU AGG (6-FAM) -3' 10014.5 10015.1 Author 
F-control C 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUfrGfrC frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10553.2 10552.8 Author 
F-control U 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUfrGfrU frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10554.2 10554.0 Author 
F-d(0) C 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUfrGC frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10535.2 10536.1 Author 
F-d(0) U 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUfrGU frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10536.2 10536.9 Author 
F-d(-1:0) C 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUGC frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10517.2 10517.8 Author 
F-d(-1:0) U 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG frUGU frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10518.2 10518.7 Author 
F-d(-2:0) C 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG UGC frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10499.2 10500.1 Author 
F-d(-2:0) U 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUfrG UGU frGfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10500.2 10500.9 Author 
F-d(-3:+1) C 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUG UGC GfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10463.2 10463.9 Author 
F-d(-3:+1) U 5'- frGfrGfrA frAfrGfrG frAfrAfrG frUfrUG UGU GfrAfrG frUfrGfrG frGfrGfrU frGfrGfrU frAfrGfrG (6-FAM) -3' 10464.2 10464.5 Author 
S30-ATX 
Series     
S30-ATC 5'- GGA AGG AAG TTG ATC GAG TGG GGT GGT AGG (6-FAM) -3' 10081.6 10081.6 Author 
S30-ATU 5'- GGA AGG AAG TTG ATU GAG TGG GGT GGT AGG (6-FAM) -3' 10082.6 10082.5 Author 
S30-ATmC 5'- GGA AGG AAG TTG ATmC GAG TGG GGT GGT AGG (6-FAM) -3' 10095.7 10095.6 Author 
S30-ATT 5'- GGA AGG AAG TTG ATT GAG TGG GGT GGT AGG (6-FAM) -3' 10096.7 10096.7 Author 
S30-AThmC 5'- GGA AGG AAG TTG AThmC GAG TGG GGT GGT AGG (6-FAM) -3' 10111.6 10111.5 Author 
S30-AThmU 5'- GGA AGG AAG TTG AThmU GAG TGG GGT GGT AGG (6-FAM) -3' 10112.6 10112.6 Author 
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S30-AT(5F)C 5'- GGA AGG AAG TTG AT(5F)C GAG TGG GGT GGT AGG (6-FAM) -3' 10099.6 10099.6 Author 
S30-AT(5F)U 5'- GGA AGG AAG TTG AT(5F)U GAG TGG GGT GGT AGG (6-FAM) -3' 10100.6 10100.4 Author 
S30-
AT(5OH)C 
5'- GGA AGG AAG TTG AT(5OH)C GAG TGG GGT GGT 
AGG (6-FAM) -3' 10097.6 10097.7 Author 
S30-
AT(5OH)U 
5'- GGA AGG AAG TTG AT(5OH)U GAG TGG GGT GGT 
AGG (6-FAM) -3' 10098.6 10098.5 Author 
S30-AT(5Br)C 5'- GGA AGG AAG TTG AT(5Br)C GAG TGG GGT GGT AGG (6-FAM) -3' 10160.5 10160.4 Author 
S30-AT(5Br)U 5'- GGA AGG AAG TTG AT(5Br)U GAG TGG GGT GGT AGG (6-FAM) -3' 10161.5 10161.3 Author 
S30-TGX 
Series     
S30-TGC 5'- GGA AGG AAG TTG TGC GAG TGG GGT GGT AGG (6-FAM) -3' 10097.6 10097.8 Author 
S30-TGU 5'- GGA AGG AAG TTG TGU GAG TGG GGT GGT AGG (6-FAM) -3' 10098.6 10098.6 Author 
S30-TGmC 5'- GGA AGG AAG TTG TGmC GAG TGG GGT GGT AGG (6-FAM) -3' 10111.7 10111.9 Author 
S30-TGT 5'- GGA AGG AAG TTG TGT GAG TGG GGT GGT AGG (6-FAM) -3' 10112.7 10112.7 Author 
S30-TGhmC 5'- GGA AGG AAG TTG TGhmC GAG TGG GGT GGT AGG (6-FAM) -3' 10127.6 10127.4 Author 
S30-TGhmU 5'- GGA AGG AAG TTG TGhmU GAG TGG GGT GGT AGG (6-FAM) -3' 10128.6 10128.6 Author 
S30-TG(5F)C 5'- GGA AGG AAG TTG TG(5F)C GAG TGG GGT GGT AGG (6-FAM) -3' 10115.6 10115.4 Author 
S30-TG(5F)U 5'- GGA AGG AAG TTG TG(5F)U GAG TGG GGT GGT AGG (6-FAM) -3' 10116.6 10116.6 Author 
S30-
TG(5OH)C 
5'- GGA AGG AAG TTG TG(5OH)C GAG TGG GGT GGT 
AGG (6-FAM) -3' 10113.6 10113.8 Author 
S30-
TG(5OH)U 
5'- GGA AGG AAG TTG TG(5OH)U GAG TGG GGT GGT 
AGG (6-FAM) -3' 10114.6 10114.5 Author 
S30-
TG(5Br)C 
5'- GGA AGG AAG TTG TG(5Br)C GAG TGG GGT GGT 
AGG (6-FAM) -3' 10176.5 10176.5 Author 
S30-
TG(5Br)U 
5'- GGA AGG AAG TTG TG(5Br)U GAG TGG GGT GGT 
AGG (6-FAM) -3' 10177.5 10177.3 Author 
S30-TG(5I)C 5'- GGA AGG AAG TTG TG(5I)C GAG TGG GGT GGT AGG (6-FAM) -3' 10223.5 10223.6 Author 
S30-TG(5I)U 5'- GGA AGG AAG TTG TG(5I)U GAG TGG GGT GGT AGG (6-FAM) -3' 10224.5 10224.5 Author 
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Complement
Strands 
AGC-
Complement 5'- ATA ACT TAA CTA GCT TAA CTT AAT TCT -3' 8191.4 8196.9 IDT 
Bubble 5-
Complement 5'- ATA ACT TAA CTT TGA AAA CTT AAT TCT -3' 8215.4 Not Done IDT 
GTC-
Complement 5'- ATA ACT TAA CTA GAC TAA CTT AAT TCT -3' 8256.4 8261.2 IDT 
Switch 
Complement 
5'- CCA GCC CAG CCT ATT CCA GCC TAG CTC AGC TCA 
TTC CCA GCT CAT -3' 13557.8 13558.5 IDT 
TAC-
Complement 5'- ATA ACT TAA CTA GTA TAA CTT AAT TCT -3' 8215.4 8215 IDT 
TTC-
Complement 5'- ATA ACT TAA CTA GAA TAA CTT AAT TCT -3' 8224.4 8224.1 IDT 
TGC-
Complement 5'- CCT ACC ACC CCA CTC GCA CAA CTT CCT TCC -3 8887.8 8888.3 IDT 
Cy5-Primer 5'- (Cy5) CAC CCC AC -3' 2832.2 2831.5 IDT 
S30-ATC-
Comp CCT ACC ACC CCA CTC GAT CAA CTT CCT TCC 8902.8 Not Done IDT 
S30-TGC-
Comp CCT ACC ACC CCA CTC GCA CAA CTT CCT TCC 8887.8 Not Done IDT 
MBP-Control 
Cassette 
Mutagenesis 
    
Forward 5’- TCG ACA TGA GAT AGC CTG CTG ATG AAC CGT CGT AAA TTT CTG TAT CAG TT -3’ 15390.0 15391.4 IDT 
Reverse 5’- CTA GAA CTG ATA CAG AAA TTT ACG ACG GTT CAT CAG CAG GCT ATC TCA TG -3’ 15377.0 15377.4 IDT 
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2.3 Biochemical Deamination Assays 
2.3.1 AID/APOBEC Deaminase Incubations 
Deaminase assays were performed essentially as previously described (157).  Specified 
concentrations of oligonucleotide and deaminase enzyme were co-incubated in the presence of 
1X buffer DA (20 mM Tris-HCl pH 8.0, 1 mM Dithiothreitol, 1 mM EDTA) at 30 °C for times 
ranging from 1 minute to 12 hours as indicated.  For chimeric substrates without any RNA 
content, reactions were supplemented with 1 U of RNAse A (NEB).  For chimeric substrates with 
RNA content, reactions were supplemented with 5 U RNAse OUT (Invitrogen) to inhibit RNAse 
activity.  Following incubation, deaminase enzymes were inactivated by incubation at 95 °C for 20 
minutes.  Subsequent to incubation with deaminase enzymes, oligonucleotides were screened for 
deamination with one of several downstream assays. 
2.3.2 DNA Glycosylase-Based Deamination Assay 
 The traditional biochemical assay for detection of cytosine deamination utilizes Uracil 
DNA Glycosylase (UDG).  UDG excises any uracil bases, generating an abasic site that may be 
cleaved by treatment with hot alkali.  Following incubation with AID, substrates were incubated 
with 0.3 U/µL UDG (NEB) at 37 ºC for 12 hours in 1X DA buffer.  UDG digestion reactions were 
quenched by addition of formamide and 150 mM NaOH (final concentration: 50% v/v) to promote 
base-mediated cleavage of the abasic sites.  Samples were run on a denaturing PAGE gel and 
imaged on a Typhoon 9400 scanning gel reader (Amersham Biosciences).  Substrate and 
product band intensities were quantified using QuantityOne (BioRad), and background intensities 
were subtracted.  Total fraction of deamination was measured as the intensity of the product band 
divided by the sum of the intensities of both the product and substrate bands. 
 UDG is unreactive to many uracil analogs that contain substitutions at the 5-position of 
the base.  Therefore, to assay deamination of modified, 5-substituted cytosines, additional DNA 
Glycosylase-based assays were developed with two glycosylases that are tolerant of these 
substitutions: TDG and SMUG.  After incubation with deaminase enzymes, excess 
complementary oligonucleotide was added (150 nM reaction oligonucleotide to 250 nM 
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complement) and annealed to substrate oligonucleotide by slow cooling from 95 ºC.  Duplexed 
DNA (final concentration 100 nM) was incubated with the appropriate glycosylase.  For hSMUG 
reactions, 140 nM hSMUG in 1X Buffer DA with 0.1 mg/mL BSA and incubated at 37 ºC for 45 
min.  For TDG reactions, 1.6 µM TDG was used in 1X Buffer DA supplemented with 0.1 mg/mL 
BSA, and reactions were incubated at 16 ºC for 12 hrs.  DNA glycosylase reactions were 
quenched in 50% formamide (v/v) and 150 mM NaOH and heated to 95 ºC for 20 minutes to 
cleave the abasic sites generated by glycosylases.  Deamination was then quantified as 
described above for UDG. 
 For all glycosylases, cleavage of respective deamination products was incomplete and, 
therefore, an incomplete measure of deamination.  To account for incomplete excision of 
deaminated bases, standard curves for quantifying the fraction of deaminated product were 
generated using S30-ATX substrates (X = C/mC/hmC) and S30-ATY products (Y = U/T/hmU), 
mixed in various ratios to 100 nM total concentration and duplexed with excess complementary 
strand S30-ATC-Comp.  Duplexes were then incubated with UDG (for C/U), SMUG (for 
hmC/hmU) or TDG (for mC/T).  When the BER-coupled assays are performed with 100 nM 
duplex DNA, the glycosylases can be used to detect 0.5 nM product.  Identical conditions were 
used to generate standard curves with the unnaturally modified S30-TGX substrates and S30-
TGY products, with UDG (for (5F)C/(5F)U) and SMUG (for (5OH)C/5(OH)U, (5Br)C/(5Br)U and 
(5I)C/(5I)U). The calculated fraction of cleaved product was determined by the intensity of the 
fluorescent product over the total product plus substrate. For all deamination assays the actual 
fraction of deaminated product was determined with reference to the standard curve generated 
for the corresponding glycosylase.  Additionally, these standard curves serve as a reference for 
the lower limits of detection for deamination of each modified cytosine species. 
2.3.3 Restriction Endonuclease-Based Deamination Assay 
Several of the chimeric nucleic acid substrates in this study contain cytosine analogs 
bearing modifications to the 2’-position of the nucleotide sugar.  These modifications are not 
tolerated by DNA glycosylases and necessitate a novel assay to screen for deamination.  We 
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found that restriction endonucleases were surprisingly tolerant to DNA substrates containing 
sugar modifications at a single nucleotide.  Following incubation with deaminase enzymes, 
oligonucleotides were annealed to an appropriate complementary strand at a concentration of 50 
nM substrate to 100 nM complement, thereby completing a palindromic duplexed substrate for 
restriction endonucleases.  Oligonucleotides were annealed by incubation at 75 °C for 5 minutes 
and slow cooling to 37 °C.  20 nM of duplexed DNA was incubated with 0.2 Units/µL FspBI 
(Fermentas) or BfaI (NEB) restriction endonucleases at 37 °C for 3 hours.  Digestion reactions 
were quenched and denatured by addition of formamide (final concentration: 50% v/v) and 
incubation at 95 °C for 20 minutes.  Samples were run on a denaturing 20% acrylamide/TBE/urea 
polyacrylamide gel (PAGE) at 50 °C and imaged on a Typhoon 9400 scanning gel reader 
(Amersham Biosciences).  FspBI could accurately discriminate between a C:G match or a U:G 
mismatch within its recognition sequence, as could the isoschizomer BfaI, suggesting that other 
DNA endonucleases may be able to recognize chimeric non-DNA substrates. 
To determine whether FspBI was capable of completely cleaving unreacted cytosine 
substrates, a standard curve was generated for quantifying the fraction of deaminated product 
from the FspBI assay.  D-rC substrates and D-rU products were mixed in various ratios and 
assayed with the FspBI restriction endonuclease in triplicate.  Observed fraction of D-rU was 
graphed as a function of actual fraction of D-rU, demonstrating a strong linear correlation.  The 
standard curve was also able to serve as an estimate of the lower limit of detection of 
deamination for the assay. 
2.3.4 Reverse Transcriptase-based Deamination Assay 
 Substrates containing prolonged stretches of 2’-fluroribonucleotides were not substrates 
for either DNA glycosylases or restriction endonucleases, and a novel assay was required to 
assess their reactivity for deamination.  We found that Reverse Transcriptase was able to tolerate 
templates containing 2’-fluororibonucleotides and chimeric templates containing both 2’-
fluororibo- and 2’-deoxynucleotides.  Following incubation with AID, a 5'-Cy5-labeled primer 
[Table 1] was annealed to oligonucleotide substrate (166 nM substrate: 83 nM primer) by 
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incubation at 75 °C for 5 minutes and slow cooling to 20 °C.  50 nM primer/template duplexes 
were extended by MuLV Reverse Transcriptase (New England Biolabs) in the presence of 1 mM 
ddATP and 100 µM dCTP/dGTP/dTTP at 25 °C for 4 hours in polymerase buffer (10 mM Tris HCl 
pH 7.9, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT).  Primer extension reactions were quenched by 
addition of formamide (final concentration: 50% v/v) containing 1 µM TGC-complement [Table 1] 
to denature primer-template duplexes and prevent reannealing of the primer strand.  Samples 
were run on a denaturing PAGE gel, imaged using the Cy5 label for detection and quantified as 
described above. 
2.4 Protein Binding Assays 
Previous experiments assessing the binding capacity of AID/APOBEC deaminases have 
predominantly relied on Electrophoretic Mobility Shift Assays (EMSA).  This technique does not 
lend itself to quantitative analysis of protein binding, given the shifting equilibrium dynamics 
between protein and substrate that occur during electrophoresis.  Therefore, we turned to 
Fluorescence Anisotropy.  5 nM oligonucleotide substrate was incubated with increasing 
concentrations of protein under the same buffer conditions used in deaminase assays at room 
temperature (n=3 replicates).  Fluorescence polarization was measured using a Panvera Beacon 
2000 Fluorescence Polarization system.  Polarization values were graphed as a function of 
enzyme concentration in GraphPad Prism.  A one-site binding, non-linear regression was fit to the 
data, which yielded dissociation constants (Kd) and maximum polarization values for each 
substrate.  For each substrate, values were normalized to maximum and minimum polarization 
values to yield total fraction of substrate bound. 
2.5 Cellular Deamination Assays 
2.5.1 Transient Expression of Deaminases and other DNA-modifying Enzymes 
All cell culture and transfections were performed by the laboratory of Yi Zhang.  TDG, 
mouse APOBEC1 (mAPOBEC1) and mouse APOBEC3 (mAPOBEC2) were each cloned from 
pCMV-SPORT6 vectors (Open Biosystems) into a FLAG-tagged pcDNA3 vector (pcDNA3β-
FLAG). Mouse APOBEC2 (mAPOBEC2) was amplified from mouse embryonic stem cell cDNA 
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and cloned into pcDNA3β-FLAG.  The cloned TET2 construct, untagged human AID and the 
catalytic mutant E58A of hAID were previously described. A synthetic gene encoding UGI was 
cloned into pIRESneo3 (Clontech).  18 hrs after plating 8x105 HEK293T cells, cells were 
transfected with pcDNA3β-FLAG-TET2 (2 µg) and pcDNA3β-FLAG containing the indicated 
enzyme (1 µg), using Fugene HD transfection reagents (Roche).  For experiments with UGI, 
transfections were done with UGI-pIRESneo3 (1 µg) and the indicated deaminase expression 
vector or controls.  48 hrs after transfection, cells were harvested for analysis of protein level and 
genomic DNA.  Equal concentrations of cells, sonicated and boiled in protein loading buffer, were 
assayed by western blotting using a polyclonal α-AID antibody, α-AID 30F12 (Cell Signaling) or 
monoclonal α-FLAG antibody (Sigma).  Loading was controlled by probing with α-tubulin (Sigma). 
2.5.2 Mass Spectrometric Experiments 
Mass spectrometric experiments were performed by the laboratory of Yi Zhang, 
essentially as previously described (14).  Briefly, 2.5 µg genomic DNA, isolated using the DNeasy 
Kit (Qiagen), was heat-denatured, hydrolyzed with 90 U of Nuclease S1 (Sigma) in Buffer (0.5 
mM ZnSO4, 14 mM sodium acetate, pH 5.2) at 37 °C for 1 hour, followed by the addition of 5 µL 
10X Buffer 2 (560 mM Tris-Cl, 30 mM NaCl, 10 mM MgCl2, pH 8.3), 0.5 µg of phosphodiesterase 
I (Worthington) and 2 U of Calf Intestinal Alkaline Phosphatase (New England Biolabs) for an 
additional 1 hour (final volume 50 µL).  Digested DNA was then filtered with Nanosep3K (Pall 
Corporation) and 15 µL of filtered samples were subjected to LC-MS/MS analysis as described 
previously with an additional transition for hmU (m/z 259.0 to 125.0) and for dU (m/z 229.0 to 
113.0). 
2.5.3 Deaminase and Base Excision Activity of Nuclear Lysates 
Nuclear lysates were prepared from HEK293T cells as previously described (22).  Cells 
were resuspended in a buffer containing 10 mM Hepes-OH [pH 7.5], 10 mM NaCl, 1.5 mM MgCl2, 
0.5 mM PMSF, and 1 mM DTT and lysed by passage through a high-gauge needle.  Crude nuclei 
were pelleted by centrifugation at 800g, and further lysed in 20 mM Hepes-OH (pH 7.5), 420 mM 
NaCl, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM PMSF, and 1 mM DTT.  Following 
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removal of insoluble debris by centrifugation, nuclear lysates were dialyzed into a buffer 
containing 20 mM Hepes-OH (pH 7.5), 100 mM NaCl, 2 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 
and 5% glycerol, and stored at -80 ºC. 
For analysis of deaminase activity, lysates (final protein concentration 0.3 µg/µL) were 
incubated with single-stranded oligonucleotide substrates (2 µM) in 1X Buffer DA and 0.1 mg/µL 
BSA, for 30 minutes. Reactions were quenched by addition of phenol:chloroform:isoamyl alcohol 
(25:24:1). To the DNA isolated from the aqueous phase, formamide and NaOH were added (50% 
v/v, 150 mM final concentrations). Samples were heated for 20 minutes (95 ºC), separated by 
denaturing PAGE and analyzed as described for deamination assays.	  	  
For analysis of base excision activity against uracil or hmU in nuclear lysates, lysates 
(final concentration 0.2 µg/µL) were pre-incubated at 37 ºC for 20 minutes before addition of 1 µM 
duplex DNA. Reactions were quenched and analyzed as described above. 
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CHAPTER 3: NUCLEIC ACID DETERMINANTS FOR SELECTIVE 
DEAMINATION OF DNA OVER RNA BY ACTIVATION-INDUCED DEAMINASE 
AND APOBEC1 
3.1 Introduction 
 In the life of the cell, enzymes must sort through a complex milieu of biomacromolecules 
to identify their proper substrates and perform their intended function.  For enzymes that target 
nucleic acids, distinguishing RNA from DNA presents a notably critical challenge.  Within the 
AID/APOBEC family, the physiologic targets have been well-identified, but the mechanisms of 
selectivity remain unknown.  Historically, this question has been most relevant to AID.  Therefore, 
AID’s ability to discern between the two nucleic acids serves as the focus of this chapter and as a 
window into the preferences of the larger AID/APOBEC family. 
3.1.1 DNA Deamination Model for Role of Activation-Induced Deaminase in Antibody 
Maturation 
When AID was initially discovered, the closest known homolog was APOBEC1, an RNA 
deaminase that introduces a premature stop codon in the mRNA of apolipoprotein B (87).  From 
this observation, it was assumed that AID was also an RNA deaminase; however, several lines of 
evidence have subsequently challenged this initial assumption in favor of a DNA deamination 
model.  Early studies showed that overexpressed AID is capable of mutating the E. coli genome, 
and mutations could be enhanced by inhibiting or eliminating uracil DNA glycosylase (UDG), the 
base excision repair enzyme that accounts for the majority of uracil excision within the cell (116, 
158).  In mice and humans, UDG and the DNA mismatch repair enzyme Msh2 are required for 
SHM and CSR, providing physiological evidence for the significance of AID-generated 
deoxyuracil in antibody maturation (159-162).  The evolving model of DNA deamination has been 
subsequently bolstered by in vitro biochemical studies on purified AID.  The enzyme was shown 
to carry out deamination of single-stranded DNA oligonucleotides, without observable activity on 
single-stranded RNA, double-stranded DNA, or RNA-DNA hybrids (16, 115, 163, 164).  Most 
recently, RNA sequencing has failed to demonstrate any AID-dependent RNA editing in activated 
B-cells (165), and AID-dependent accumulation of deoxyuracil has been demonstrated within the 
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Ig locus (88).  This direct observation of uracil in genomic DNA provides the strongest evidence to 
date in favor of the DNA deamination model, and this model is now widely accepted.  
Despite a compelling body of evidence in favor of the DNA deamination model, several 
key questions remain unanswered regarding AID’s mechanism of action.  AID’s promiscuous 
binding interactions with RNA (16, 115) demonstrate the lack of any molecular explanation for 
AID’s nucleic acid selectivity.  In fact, purified AID requires RNase treatment before DNA 
deamination activity can be observed, suggesting that RNA can competitively bind in the 
enzyme’s nucleic acid binding site (16).  A similar pattern of DNA deamination despite RNA 
binding is seen with APOBEC3 homologs of AID that contribute to restriction of retroviruses such 
as HIV.  In this case, RNA binding appears critical for the appropriate packaging of these 
restriction factors within their retroviral targets (166-168).  Similar to AID, RNA deaminase activity 
has never been described for any APOBEC3 family members.  Thus, there remains the persistent 
and unanswered question of how AID can freely interact with both RNA and DNA, yet retain 
catalytic specificity for DNA.  Given the established and emerging roles of AID/APOBEC biology, 
there is a pressing need to elucidate the mechanisms of AID’s nucleic acid selectivity to provide 
insights into how cytosine is recognized and deaminated.   
3.1.2 Experimental Approach 
 To elucidate the answers to this question, we interrogated the molecular basis of AID’s 
selectivity for DNA over RNA.  RNA is distinguished from DNA by the presence of the 2'-(R)-
hydroxyl group in the sugar of the nucleotide building blocks [Figure 15A].  Given that this 
hydroxyl group introduces a steric constraint and alters the conformational preferences of the 
nucleotide [Figure 15B], we reasoned that this 2'-substituent of the target cytosine itself could be 
an important determinant of deamination selectivity.  To test this hypothesis, we synthesized 
chimeric substrates that contain 2'-modifications in a single target cytosine embedded within an 
otherwise DNA backbone: DNA with a single 2'-deoxycytidine (D-dC), 2'-ribocytidine (D-rC), 2'-
fluororibocytidine (D-frC), 2'-arabinocytidine (D-aC), or 2'-fluoroarabinocytidine (D-faC) [Figure 
15C].  This target cytosine was placed within an AGCT hotspot motif to ensure physiologically-
42	  
	  
relevant sequence specificity and efficient deamination.  We then assayed these substrates with 
purified, recombinant AID to test for differential reactivity. 
	  
Figure 15: Nucleotide sugar pucker as a potential basis for DNA selectivity.  (A) DNA and 
RNA are distinguished by the presence of a 2’-(R)-hydroxyl substitution, as indicated in magenta.  
(B) 2’-substitution affects the equilibrium of nucleotide sugar conformations.  DNA prefers a C(2’)-
endo conformation, commonly known as ‘south’.  RNA prefers a C(3’)-endo conformation (or 
‘north’).  (C) Chimeric DNA substrate design.  Sequence of chimeric substrate is listed, with 
chimeric cytosine indicated in magenta.  Chimeric cytosine conformers vary in their 2’-
substituents. 
3.2 Results 
3.2.1 2’-Substituents of Target Cytosine Regulate Deamination by AID 
Traditional biochemical assays for deamination rely upon UDG for detection of reaction 
products.  Since UDG does not recognize several nucleotide conformers used in our chimeric 
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substrates, we developed a novel assay to screen for deamination and found that DNA restriction 
endonucleases were capable of assaying the full panel of substrates [Figure 16A].  Specifically, 
the restriction endonuclease FspBI was surprisingly tolerant to the presence of a chimeric non-
DNA base within its target, and could accurately discriminate between a C:G match or a U:G 
mismatch within its recognition sequence [Figure 16B].  Of note, the isoschizomer BfaI also 
tolerated these same chimeric substrates [Figure 16C], suggesting that other DNA 
endonucleases may be able to recognize chimeric non-DNA substrates. 
	  
Figure 16: Restriction-endonuclease-based assay for deamination.  (A) Assay design.  
Following AID incubation, substrates are duplexed to a complementary strand that completes a 
palindromic duplex substrate for endonuclease cleavage.  If the target cytosine is unreacted, the 
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duplex is cleaved; if target cytosine is deaminated to uracil, the duplex is not cleaved.  (B) 
Reactivity of chimeric DNA substrates against FspBI.  Above each cytosine conformer, the 
nucleotide sugar is shown.  (C) Reactivity of chimeric DNA substrates against BfaI. 
As expected, one-hour incubation of AID with the D-dC substrate yielded robust 
deamination [Figure 17A].  This substrate is entirely DNA and represents the canonical substrate 
for deamination.  D-rC differs from D-dC only by the presence of a 2'-hydroxyl at the target 
cytosine; the presence of this single molecular substitution was sufficient to compromise 
deamination of the otherwise entirely DNA substrate.  Incubation of AID with D-frC yielded 
similarly negligible deamination, demonstrating that both 2'-hydroxyl- and 2'-fluoro- substitutions 
with (R)-stereochemistry impair deaminase activity.  By contrast, AID more efficiently deaminated 
cytosine substrates when the 2'-hydroxyl- and 2'-fluoro- substituents were present in epimeric, or 
inverted, configurations in D-aC and D-faC.  The trend observed with the one-hour incubation 
was reflected in different initial rates of turnover at early time points [Figure 17B].    
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Figure 17: 2’-substitution of target cytosine is sufficient to disrupt AID deaminase activity.  
(A) Chimeric DNA substrates incubated with AID for 1 hour and assayed for deamination with 
restriction-endonuclease-based assay.  Target nucleotide sugar is shown above each respective 
substrate.  (B) Chimeric DNA substrates (250 nM) incubated with AID (500 nM) for multiple time-
points up to one hour.  Total product formation is graphed as a function of time (n=3 replicates, 
standard deviation shown).  White symbols indicate target cytosines that prefer C(2’)-endo 
conformation, while black symbols indicate a preference for C(3’)-endo conformation.  
To confirm the reproducibility of sensitivity to the 2’-(R)-hydroxyl, we designed an 
additional series of substrates to test the impact of this substitution [Figure 18A].  Though these 
substrates all bear some deviation from those described in Figures 16 and 17, they remained 
amenable to the restriction-endonuclease-based assay for deamination.  First, we evaluated the 
reactivity of ribocytidine within the context of a coldspot and alternative hotspot [Figure 18B].  
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Neither of these conditions yielded detectable deamination.  Deoxycytidine controls were ready 
deaminated, albeit at different levels as expected.  Given that, physiologically, AID is thought to 
target cytosine in transcription bubbles, we also evaluated differential reactivity of the two 
cytosine conformers within a bubble substrate.  The bubble was formed by annealing a single-
stranded substrate to a complementary strand bearing a mismatch of 5 nucleotides.  This result 
confirmed the selectivity seen with the coldspot and alternative hotspot.  Additionally, the same 
degree of selectivity was seen with a 7-nucleotide bubble substrate as well (data not shown).  
Lastly, we evaluated AID’s selectivity within a physiologically relevant sequence, chosen from the 
consensus sequence for the mouse Sα switch region.  This sequence contained multiple hotspots 
for AID deamination; however, only one of those hotspots overlapped with the FspBI recognition 
sequence, enabling a clear readout for deamination.  AID selectively deaminated the substrate 
containing deoxycytidine and not ribocytidine, ultimately validating the sensitivity of AID to the 2’-
(R)-hydroxyl substitution of cytosine across a full panel of four additional substrates (149, 169).   
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Figure 18: Incubation of AID with chimeric substrates in alternative sequence contexts.  
(A) Sequences of additional chimeric DNA substrates containing dC or rC conformers at the 
target position.  Substrates include coldspot and alternative hotspot targeting motifs; a bubble 
substrate, in which substrate is annealed to a complementary strand containing 5 mismatched 
nucleotides surrounding the target cytosine; and a single-stranded DNA oligonucleotide sequence 
derived from a consensus sequence for the mouse Sα region.  For consensus sequence, 
additional AGCT hotspot motifs are underlined.  All substrates were assayed for deamination with 
restriction-endonuclease-based assay.  (B) Additional chimeric DNA substrates (250 nM) were 
incubated with AID (500 nM) for 1 hour and assayed for deamination with the FspBI restriction-
endonuclease-based assay.  These results confirm the sensitivity to 2’-(R)-hydroxyl substitution 
at the target cytosine in all contexts tested, consistent with results from Figure 17. 
We used a truncated form of AID lacking its terminal exon (residues 181-198) in our 
experiments.  This version of AID has previously been shown to retain identical sequence 
targeting and has increased enzymatic activity compared to the full-length enzyme (140), thereby 
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increasing the dynamic range of the enzyme’s reactivity and permitting the study of less favored 
substrates.  Nevertheless, to confirm that this truncation does not affect AID’s sensitivity to 2’-
subtitution of the target cytosine, we purified full-length AID and repeated our experiments.  As 
expected, when we also assayed the chimeric substrates with full-length AID, the enzyme 
demonstrated similar preferences, although overall enzymatic activity was diminished [Figure 19]. 
	  
Figure 19: Full-length AID demonstrates similar reactivity compared to truncated version.  
Chimeric DNA substrates (250 nM) incubated with full-length AID (500 nM) for 1 hour and 
assayed for deamination with restriction-endonuclease-based assay.  Full-length AID shows a 
pattern of preferences for chimeric substrates that is consistent with that in Figure 17, obtained 
using the truncated version of AID. 
To obtain a more rigorous comparison between substrates, we returned to the 
hyperactive, truncated version of AID and repeated our deaminase assays under extended-
incubation conditions.  For a quantitative comparison of substrate reactivity, we further 
determined product formation as a function of enzyme concentration with extended twelve-hour 
incubations.  We focused on a range where product formation was linearly dependent upon 
enzyme concentration and compared the overall substrate reactivity by normalization to those 
values obtained with D-dC [Figure 20A].  Values were obtained for all substrates except D-rC, as 
its linear regression did not significantly deviate from zero.  This necessitated the determination of 
the lower limits of detection for the FspBI restriction-endonuclease-based assay [Figure 20B].  A 
standard curve was created by mixing D-rC and D-rU in various ratios, assaying with FspBI, and 
comparing the observed and actual percentages of D-rU.  The standard curve demonstrated that 
the FspBI provides an accurate quantification of product formation.  At the lower end of the curve, 
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we determined the limit of detection of deamination as 0.5%, making the assay a sensitive 
measure of D-rC detection. 
Based on the lower limits of detection for D-rC deamination, the D-dC substrate was 
deaminated over 500-fold more efficiently than the D-rC substrate, highlighting AID’s striking 
degree of sensitivity to the 2'-(R)-hydroxyl at the target cytosine [Figure 20A].  The full degree of 
sensitivity is like greater than this value, limited here by the inefficient DNA deaminase activity of 
AID and our limits of detection for D-rC deamination.  When comparing epimers of the same 
substituent (D-rC vs D-aC for 2'-hydroxyl-; D-frC vs D-faC for 2'-fluoro-), the arabinosyl epimers 
D-aC and D-faC were preferred by more than an order of magnitude.  For the 2’-fluoro 
substituent, the arabinosyl epimer was preferred nearly 40-fold.  Though the estimate for the 2’-
hydroxyl substituent is constrained by the lower limit of detection, the arabinosyl epimer is 
preferred at least 40-fold.  Thus, quantitative analysis confirms AID’s sensitivity to 2’-substitution 
of cytosine and reveals a strong preference for arabinosyl conformers over ribosyl counterparts. 
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Figure 10: Quantitative assessment of AID deamination of chimeric DNA substrates.  (A) 
Deaminase activity of AID against chimeric DNA substrates (250 nM) as a function of enzyme 
concentration.  Product formation of deamination of chimeric substrates is shown as a function of 
increasing AID concentration (n = 3 replicates; standard deviation shown).  Absolute and relative 
deaminase activities were determined by linear regression and are listed with each substrate in 
figure legend.  Linear regression of data for D-rC does not significantly deviate from zero; 
therefore, values for D-rC are based on assay detection limits determined in part B.  (B) 
Determination of lower limit of detection for D-rC deamination.  A standard curve is shown 
consisting of D-rC and D-rU mixed in varying ratios (n=3 replicates, standard deviation shown).  
Inset is the magnification of the low end of the standard curve.  Statistical significance from zero 
was determined by a student’s T-test.  NS: p > 0.05, Single Asterisk: p < 0.05, Double Asterisk: p 
< 0.005.  0.5% D-rU in total reaction is statistically significant limit of uracil detection, yielding 
upper limit of D-rC deaminase activity as 0.003 nM Product/nM AID. 
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With a clear pattern of differential reactivity against chimeric DNA substrates, we wanted 
to determine whether these results might result from preferential binding.  Using fluorescence 
polarization, we determined that AID bound with a similar affinity across the series of substrates, 
suggesting that altered binding was not a sufficient explanation for selectivity [Figure 21A, B].  
This is consistent with previous studies that have found limited changes in binding affinity when 
only a few bases are modified within a larger DNA substrate.  Notably, because AID was purified 
as a recombinant fusion protein with maltose-binding protein (MBP), we examined binding with 
MBP alone to ensure that substrate binding was specifically due to AID.  The failure to induce any 
change in polarization confirms that MBP does not contribute to substrate binding [Figure 21C]. 
	  
Figure 21: AID binding to chimeric DNA substrates.  (A) Fluorescence polarization assay for 
determination of binding affinity. Decreased tumbling upon formation the enzyme-nucleic acid 
complex leads to increase in fluorescence polarization.  (B) Fluorescence polarization of chimeric 
DNA substrates (5 nM) in the presence of increasing concentrations of AID (n=3 replicates, 
standard deviation shown).  Y-axis depicts the fraction of bound substrate.  Kd values are 
reported in figure legend.  Nanomolar concentrations of MBP-AID fusion protein were sufficient to 
induce changes in fluorescence polarization, indicative of protein binding.  (C) Fluorescence 
polarization of chimeric DNA substrates (5 nM) in the presence of increasing concentrations of 
MBP (n=3 replicates).  Micromolar concentrations of MBP alone were unable to induce any 
change in fluorescence polarization, confirming that binding affinities demonstrated in part B are 
specifically a result of AID in the MBP-AID fusion protein. 
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3.2.2 2’-Substituents of Target Cytosine Regulate Deamination by APOBEC1 
The notion that AID could deaminate RNA originated from its homology to APOBEC1 
(87).  Despite this homology, AID acts on the immunoglobulin locus DNA, while APOBEC1 is 
physiologically known to target apolipoprotein B mRNA.  Given the similarities and contrasts 
between these two deaminases, we sought to determine APOBEC1’s sensitivity to 2'-substitution 
of the target cytosine.  As with AID, we created a series of chimeric DNA substrates containing 2'-
deoxycytidine, 2'-ribocytidine, and 2'-fluororibocytidine embedded within a sequence context 
preferred by APOBEC1 (A1-D-xC, Table 1) (110).  These substrates were incubated with 
APOBEC1 and evaluated using the FspBI restriction-endonuclease-based assay for deamination. 
 We found that APOBEC1 readily deaminated the A1-D-dC substrate, in line with previous reports 
that have demonstrated the enzyme’s robust DNA deaminase activity [Figure 22] (115-117).  
Remarkably, despite its physiological targeting of RNA, APOBEC1 deaminated A1-D-dC more 
efficiently than the A1-D-rC and A1-D-frC substrates, a trend additionally reflected in the 
differential reactivity at early time points.   
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Figure 22: 2'-substitution of target cytosine disrupts APOBEC1 deaminase activity.  (A) 
Restriction-enzyme based assay of chimeric substrates (250 nM) in the presence of APOBEC1 
(1.5 µM) for 1 hour.  (B) Chimeric substrates were incubated with APOBEC1 for various time 
points over the course of one hour.  Total product formation is graphed as a function of time (n = 
3 replicates; standard deviation shown). 
For a quantitative comparison of reactivity, as done for AID, we also determined product 
formation for each substrate as a function of APOBEC1 concentration with extended 12-hour 
incubations.  The values for each substrate were normalized to that obtained with A1-D-dC 
[Figure 23].  Whereas deamination of D-rC was undetectable in the presence of AID, APOBEC1 
yielded detectable A1-D-rC deamination.  APOBEC1 deaminated the A1-D-dC substrate 110-fold 
more efficiently than the A1-D-rC substrate and 20-fold more efficiently than the A1-D-frC 
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substrate.  Compared with AID, APOBEC1 demonstrates increased tolerance of the substrates 
containing ribosyl epimers of cytosine. 
	  
Figure 23: Quantitative analysis of APOBEC1 deaminase activity against chimeric DNA 
substrates.  Product formation of deamination of chimeric substrates (250 nM) is shown as a 
function of increasing APOBEC1 concentration for 12 hour incubations (n = 3 replicates; standard 
deviation shown).  Absolute and relative deaminase activities are listed with each substrate in 
figure legend.   
As with AID, we evaluated APOBEC1’s substrate binding affinities to rule out any 
preferential binding.  APOBEC1 bound all substrates with similarly high affinity, indicating that the 
differences in reactivity were not a function of altered binding [Figure 24].    
	  
Figure 24: APOBEC1 binding to chimeric DNA substrates.  Fluorescence polarization of 
chimeric DNA substrates (5 nM) in the presence of increasing concentrations of APOBEC1 (n=3 
replicates, standard deviation shown).  Y-axis depicts the fraction of bound substrate.  Kd values 
are reported in figure legend.  Nanomolar concentrations of MBP-AID fusion protein were 
sufficient to induce changes in fluorescence polarization, indicative of protein binding. 
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3.2.3 Minimal DNA Requirements for Deamination by AID 
Analysis of the chimeric DNA substrates demonstrated that RNA-like 2'-substitutions to 
the target cytosine are sufficient to compromise AID’s deaminase activity, underlying AID’s 
specificity for DNA.  To gain further insight into the molecular determinants of AID’s deamination 
activity, we wanted to determine whether the inverse were also true: would removal of the 2'-
substituent from the target cytosine of an RNA substrate rescue deamination?   
To address this question, we synthesized chimeric oligonucleotides consisting of 2'-
fluororibo-nucleotides (2’-F-RNA) with a varied number of DNA nucleotides embedded at the 
target cytosine and neighboring positions [Figure 25A].  2'-F-RNA was selected for its stability 
relative to RNA.  As DNA endonucleases were intolerant of these predominantly non-DNA 
substrates, we designed a primer-extension assay for deamination using reverse transcriptase 
(RT) [Figure 25B].  RT tolerated both 2'-F-RNA and our chimeric templates, properly 
incorporating the chain-terminator ddATP opposite the 0 position of the uracil product controls 
and the -2 position of cytosine substrates during primer extension [Figure 25C].   
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Figure 25: Reverse-transcriptase-based assay for deamination of chimeric 2’-F-RNA 
substrates.  (A) Substrate design.  In addition to chimeric substrates, entirely DNA and 2’-F-RNA 
substrates were designed as positive and negative controls for deamination, respectively.  (B) 
Assay design.  Primer extension in the presence of ddATP yields a 10 base pair extension 
product in the presence of deamination, and a 12 base pair extension product when the template 
strand is not deaminated.  (C) Reverse transcriptase assay using AID-incubated (1.4 µM) 
chimeric 2’-F-RNA substrates and controls (250 nM) as templates for primer extension.  
When incubated with AID for one hour, the entirely DNA control (D-control) was readily 
deaminated while entirely 2'-F-RNA substrate (F-control) was not, as expected given AID’s 
selectivity against RNA [Figure 26].  DNA at the target cytosine alone (F-d(0)) rescued 
deamination negligibly compared to the all-DNA control, indicating that removing additional 2'-
substituents from neighboring nucleotides may be necessary to rescue deamination.  Expanding 
beyond the target cytosine, removing the 2'-F from the -1 position (F-d(-1:0)) also yielded 
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negligible, though slightly increased, deamination.  On the other hand, expansion of the chimeric 
DNA patch from the -2 to the 0 position (F-d(-2:0)) fully rescued deamination to the level seen 
with the all-DNA control, as did further expansion of the DNA patch to the -3 to +1 positions (F-d(-
3:+1)).   
	  
Figure 26: Rescue of deamination of chimeric 2'-F-RNA oligonucleotides requires a DNA 
patch from positions -2 to 0.  Chimeric substrates incubated with AID for one hour and 
evaluated via the Reverse Transcriptase-based assay.  Asterisk denotes band associated with 
deaminated product.	  
To verify these results, we verified our findings using the UDG-based assay for 
deamination.  Neither the D-control nor F-control substrates were compatible with this 
deamination assay, given the overabundance of deoxyuracil in D-control and the lack of UDG 
reactivity of 2’-fluororibouracil in F-control.  Though the positive and negative controls were 
lacking, the deamination status of all chimeric substrates was accurately reported [Figure 27].  As 
before, deamination was rescued only in the F-d(-2:0) and F-d(-3:+1) substrates.  This result 
confirms the importance of the 2’-substituent at the two nucleotides upstream of the target 
cytosine.   
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Figure 27: UDG-based, alternative assay for deamination of chimeric 2’-F-RNA substrates.  
(A) After incubation with AID, the 3'-end labeled oligonucleotides are incubated with UDG, which 
generates abasic sites at deoxyuridine residues, with no significant reactivity with 2’-
fluororibouridine. Deamination of all chimeric substrates is detectable by formation of a 15 bp 
product after alkaline-induced cleavage of abasic sites. The presence or absence of dU at the -2 
position dictates whether unreacted cytosine-containing oligonucleotides generate a 17 bp 
product or the 30 bp unreacted substrate, respectively.  (B) Chimeric substrates assayed for 
deamination with UDG-based assay. As standards, controls in the absence of AID are shown with 
each substrate. For the samples that received one hour incubation with AID, minimal deamination 
is seen with F-d(0) and F-d(-1:0), while deamination is seen with F-d(-2:0) and F-d(-3:+1). This 
independent assay confirms the findings of the Reverse Transcriptase-based assay. 
To evaluate the contribution of binding to deamination, we determined AID’s binding 
affinity for 2'-F-RNA chimeras and DNA/2'-F-RNA controls by fluorescence polarization 
measurements.  AID showed a similar affinity for all the substrates, with a slight preference for 
the predominantly 2'-F-RNA substrates over the all-DNA control [Figure 28].  DNA binding affinity 
was approximately 1.5-3 fold worse than the substrates containing 2’-F-RNA.  Whereas a 
longstanding assumption has been that tighter binding is correlated with more efficient 
deamination, our results indicate somewhat to the contrary: the canonical, favored DNA substrate 
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is bound slightly less efficiently than the disfavored 2’-F-RNA substrate.  Given the similar 
conformations, 2’-F-RNA binding dynamics likely recapitulate those with true RNA.  
	  
Figure 28: AID binding to chimeric 2’-F-RNA substrates.   Fluorescence polarization of 
chimeric 2'-F-RNA substrates was determined in the presence of increasing concentrations of 
MBP-AID fusion protein (n=3 replicates, standard deviation shown). 
3.3 Discussion 
3.3.1 Mechanistic Basis for AID’s Inherent Preference for DNA Deamination 
We have demonstrated that AID’s deaminase activity is strongly influenced by the 2'-
substituents of its target nucleotides.  Introducing a single 2'-(R)-OH at the target cytosine 
nucleotide of an otherwise DNA substrate was sufficient to disrupt deaminase activity by at least 
500-fold.  Inversely, removing the 2'-fluoro substituents from the target cytosine and two 
upstream nucleotides rescued deamination of a 2’-F-RNA substrate.  These data indicate that 2'-
substitution of the nucleotide sugar is an important molecular determinant of selectivity for AID’s 
deaminase activity. 
What is the molecular basis of the deaminases’ preference for DNA over RNA?  
Biophysically, there are two closely related, principal mechanisms by which the 2'-OH substitution 
may enable them to distinguish between the two nucleic acids.  The first method of discrimination 
is steric exclusion, wherein steric interactions with the 2'-OH of RNA exclude the target 
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nucleotide.  A ‘steric gate’ mechanism has been observed in DNA polymerases (170) and base 
excision repair enzymes, including uracil DNA glycosylase (171).  While the 2'-OH provides a 
basis for steric exclusion, it also results in conformational differences between the nucleotide 
sugar of RNA and DNA, known as sugar pucker.  DNA prefers a C(2')-endo (south) conformation, 
while RNA is more restricted to an alternative C(3')-endo (north) conformation [Figure 15] (172).  
For enzymes that modify nucleic acids, alternative sugar puckers can impact the reactivity or 
positioning of the substrate in the active site by altering the angular projection of the base from 
the sugar-phosphate backbone, with RNA ligases serving as one example (173).   
AID’s relative reactivity with the chimeric DNA substrates suggests that sugar pucker of 
the target nucleotide is critical for catalysis.  Specifically, the cytosine conformers that prefer the 
C(2')-endo (south) conformation—dC, aC, and faC (174)—were readily deaminated.  Amongst 
these three substrates, D-dC was most favored over D-faC and D-aC, correlating reactivity with 
smaller 2'-(S)-substituents.  This observation suggests that steric exclusion of the 2'-substituent 
may provide a secondary factor for discrimination.  Further highlighting the importance of these 
nucleic acid determinants, the conformers that prefer the C(3')-endo (north) conformation—rC 
and frC (175)—were disfavored for deamination, even when embedded in a nucleic acid 
substrate that is otherwise entirely DNA.  Prior studies have shown that chimeric nucleotides 
embedded in DNA independently retain their sugar pucker and perturb local helix formation (176, 
177), indicating that the cytosine conformers used in this study are likely to retain their expected 
north-south conformations in our chimeric DNA substrates.  Taken together, reactivity with our 
chimeric substrates supports the notion that an isolated, disfavored sugar pucker at the target 
cytosine is sufficient to disrupt AID’s deaminase activity and underlies selectivity for DNA.  More 
broadly, this model implicates sugar pucker as a potential discrimination mechanism by which 
APOBECs and other cellular enzymes may distinguish DNA from RNA at the level of individual 
nucleotides.  
Moving beyond the target cytosine, our study shows that the 2'-substituents play a critical 
role at neighboring nucleotide positions as well.  Removal of the 2'-fluoro substituent from the -1 
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and -2 positions was necessary to rescue full deamination of 2'-F-RNA chimeric substrates.  Our 
finding regarding the significance of the -2 to 0 positions aligns well with the identification of the 
“hotspot recognition” loop within AID that specifically targets deaminase activity to the cytosine of 
WRC trinucleotide hotspots (140, 145, 146), as well as nucleoside analog interference studies 
with the homolog APOBEC3G (178).  Taken together, the most significant determinants of nucleic 
acid recognition—sugar, backbone and nucleobase recognition—appear to be confined to this 
critical trinucleotide patch spanning the -2 to 0 positions. 
3.3.2 AID’s Inherent Preferences Support the DNA Deamination Model of Antibody 
Maturation 
 The DNA deamination model for AID’s role in antibody maturation is well supported by a 
bevy of genetic, cellular, and bacterial experiments that affirm DNA as AID’s true target (137).  
The RNA deamination hypothesis has long been largely abandoned, with the exception of 
continued reports from the Honjo group that fail to demonstrate any biochemical reactivity 
between AID and ribocytidine (179).  This limited biochemical plausibility of the RNA deamination 
hypothesis is dwarfed by an abundance of evidence in favor of the DNA deamination model, 
leaving little controversy regarding AID’s true substrate.  Nevertheless, the model has suffered 
from the lack of a mechanistic basis for selectivity. 
Beyond their contributions to the body of evidence supporting the DNA deamination 
model, our biochemical insights contribute a mechanistic basis for AID’s nucleic acid selectivity.  
AID’s inherent preference for DNA over RNA is consistent with its physiologic activity.  This 
inherent preference is likely rooted in the nucleotide sugar pucker.  While these preferences were 
not assessed in vivo, it is highly likely that our in vitro biochemical characterizations accurately 
recapitulate AID’s physiologic preferences, given the preservation of other characteristics such as 
sequence targeting.  Our study additionally provides a hypothesis that will guide further 
characterization of the mechanistic basis for DNA selectivity, presumably through resolution of 
the structural characteristics of the enzyme-substrate complex. 
3.3.3 APOBEC1’s Inherent Preference for DNA Contrasts with its Physiologic RNA Activity 
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When assayed against a similar panel of chimeric DNA substrates, APOBEC1 also 
demonstrated a high degree of sensitivity to the 2'-substituent of the target cytosine.  Like AID, 
APOBEC1 favored the A1-D-dC substrate over A1-D-rC and A1-D-frC, both of which prefer the 
C(3')-endo conformation at the target base.  The similar pattern in favor of DNA deamination 
suggests that the molecular determinants of the deamination reaction have been conserved since 
the evolutionary divergence of APOBEC1 and AID, indicating that these determinants of 
deamination remain conserved across the AID/APOBEC family.   
On one hand, these inherent preferences align well with recent studies on ancestral 
homologs of APOBEC1 that suggest that the enzyme was initially a DNA deaminase and evolved 
physiological RNA deaminase activity only recently (118). On the other hand, the discordance 
between APOBEC1’s intrinsic preference for DNA and its known physiological RNA deaminase 
activity also demonstrates that an enzyme’s intrinsic preferences alone do not dictate its 
physiological activity.  Thus, our study also leaves open the possibility that AID, too, could 
overcome its intrinsic preferences within the cell, or that APOBEC1 may possess an as-of-yet 
undescribed cellular function against DNA. 
If both AID and APOBEC1 indeed have greater deaminase activity against DNA, why 
would AID physiologically target DNA and APOBEC1 target RNA?  The reason for this 
discrepancy may be two-fold.  First, AID and APOBEC1 have distinct protein-binding partners 
that recruit them to their respective target nucleic acids.  ACF recruits APOBEC1 to AU-rich 
mooring sequences on mRNA transcripts (110, 111), whereas RPA and Spt5 facilitate AID’s 
interactions with the B-cell genome (91, 93).  It is feasible that ACF induces a permissive 
conformation in enzyme or substrate, or that target RNA sites intrinsically adopt a sugar pucker 
that permits deamination.  Second, while APOBEC1 appears to prefer DNA-like sugar pucker at 
the target site, our data suggest that APOBEC1 also has a greater inherent tolerance of the rC 
substrate than AID.  When measured relative to the dC substrates, APOBEC1 deaminated its D-
rC substrates at least 4-fold more readily than AID.  As this semi-quantitative comparison relies 
on the lower-limit of detection for AID’s D-rC deaminase activity, APOBEC1’s tolerance is likely 
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greater than this conservative estimate.  Taken together, our data suggest that APOBEC1 has 
evolved two potentially distinct mechanisms to tolerate RNA for deamination.  For future study, 
our findings raise the intriguing question of how APOBEC1 overcomes its inherent preferences to 
deaminate RNA within the cell. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64	  
	  
CHAPTER 4: AID/APOBEC DEAMINASES DISCRIMINATE AGAINST 
MODIFIED CYTOSINES IMPLICATED IN DNA DEMETHYLATION 
 
4.1 Introduction 
Transcriptional variability and adaptability are particularly necessary in responding to the 
challenges of multicellular life.  As part of nature’s enzymatic toolbox, methylation of cytosine at 
the 5-position of the base represses gene expression and shapes cellular identity. The reverse of 
this process, active DNA demethylation, is equally important for cleaning the genomic slate during 
embryogenesis or achieving rapid, locus-specific reactivation of previously silenced genes.  
The mechanism of DNA methylation has been rigorously established, catalyzed by a 
family of DNA methyltransferases that initiate and maintain the epigenetic memory of the methyl 
mark.  Strikingly, the mechanisms of DNA demethylation have remained enigmatic.  Studies on 
demethylation have been marred by a long history of seemingly disparate observations that have 
failed to coalesce into a consistent model (180).  Against such a backdrop, this chapter explores 
biochemical preferences of the AID/APOBEC family to demystify the role of deamination in DNA 
demethylation.  
4.1.1 Proposed Mechanisms of DNA Demethylation 
  Although active demethylation is increasingly accepted as an important physiological 
process, its molecular basis remains controversial.  Several DNA glycosylases have been 
described in Arabidopsis that can excise mC specifically; however, mammals appear to lack this 
activity (181).  In the past several years, a wealth of new evidence has implicated several of the 
key cytosine-modifying enzymes we have reviewed, particularly the AID/APOBEC deaminases, 
TET oxidases, and DNA glycosylases (182).  Two major types of models have emerged: a 
deamination-initiated pathway and several variants of an oxidation-initiated pathway [Figure 29]. 
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Figure 29:	  Proposed non-canonical role for AID/APOBEC enzymes acting on modified 
cytosine substrates in DNA. (A) Deamination of cytosine plays known physiological roles in 
adaptive immunity (AID), innate immunity against retroviruses (APOBEC3 enzymes), and mRNA 
editing (APOBEC1). These canonical roles involve deamination of cytosine to generate uracil.  
(B) DNA demethylation involves the regeneration of unmodified cytosine from mC.  (C) Proposed 
Demethylation pathways.  The function of AID/APOBEC family members on modified cytosine 
residues remains poorly understood despite their implication in potential pathways for active DNA 
demethylation. Deamination of mC or hmC, the product of TET-mediated oxidation, could 
generate thymidine or 5-hydroxymethyluracil (hmU), respectively. Base excision repair (BER) 
could subsequently excise the deaminated bases and replace them with unmodified cytosine. An 
alternative deamination-independent pathway involves iterative oxidation, generating 5-
formylcytosine (fC) or 5-carboxylcytosine (caC). BER-mediated excision of the oxidized cytosine 
would result in reversion to unmodified cytosine.	  
 Two types of deamination-dependent mechanisms have been postulated.  In one 
scenario, deamination of mC by an AID/APOBEC enzyme generates a T:G mismatch leading to 
subsequent repair by the BER enzyme thymidine DNA glycosylase (TDG) (183).  Alternatively, 
hmC could be deaminated by an AID/APOBEC enzyme to generate 5-hydroxymethyluracil (hmU) 
which could also be reverted to cytosine by BER (32, 38).  Recent studies have also 
demonstrated the feasibility of a deamination-independent pathway for DNA demethylation 
involving oxidation of mC by TET enzymes. The product of this oxidation, hmC, can itself be 
iteratively oxidized to yield both 5-formylcytosine (fC) and 5-carboxylcytosine (caC) (14, 15). 
These higher oxidation products are detectable in the genome of embryonic stem cells and are 
good substrates for excision by TDG, which could ultimately regenerate unmodified cytosine 
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(182). Notably, deficiency in TDG, a potential common mediator in the various proposed 
pathways for DNA demethylation, is associated with developmental methylation defects and 
embryonic lethality (31, 32). 
 
4.1.2 Evidence in Support of Deamination-Dependent Demethylation and Remaining 
Questions 
 
 The plausibility of deamination-dependent demethylation has been difficult to establish 
because of the poorly characterized activities of AID/APOBEC enzymes on C5-modified 
cytosines and a lack of knowledge about the functional redundancy between AID/APOBEC family 
members (184).  Although prior studies suggest that AID’s ability to deaminate 5mC is reduced 
relative to its ability to deaminate cytosine (16, 183), other work proposes that the enzyme lacks 
any 5mC deaminase activity (19).  Additional ambiguity arises because the activities of other 
APOBEC enzymes on 5mC have not been directly investigated, and the biochemical activities of 
all AID/APOBECs against 5hmC remain entirely unknown. 
Further, the presence of numerous AID/APOBEC family members presents a substantial 
challenge to sorting out their potential roles in demethylation. A role for AID in demethylation of 
pluripotency promoters is suggested from heterokaryon-based systems for the generation of stem 
cells (185), and AID deficiency has also been found to perturb the methylome of primordial germ 
cells (186).  However, these observations are confounded by the finding that AID deficiency is 
viable in both mice and humans (87), suggesting that other deaminases might also serve 
functionally redundant roles in demethylation. In support of this proposal, APOBEC2 enzymes 
were postulated to play a role in zebrafish DNA demethylation (121) and APOBEC1 has been 
implicated in neuronal DNA demethylation (38). Thus, biochemical characterization of the 
similarities and differences between these deaminases would address the functional redundancy 
of these enzymes in DNA demethylation.  The previous implications that deaminases might be 
involved in DNA demethylation (136, 187) make it important to examine their activity on 5-
substituted cytosine bases in DNA and the plausibility of deamination-dependent DNA 
demethylation. 
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4.2 Results 
4.2.1 AID/APOBECs Preferentially Deaminate Unmodified Cytosine 
We wished to profile the reactivity of representative AID/APOBEC family members with 
modified cytosine nucleobases. We chose to investigate the mouse enzyme family, which 
possesses only a single gene for each family member, rather than the human family, where 
extensive gene duplication and specialization at the A3 locus have generated many variants. 
Mouse APOBEC1 (mAPOBEC1), APOBEC2 (mAPOBEC2), APOBEC3 (mAPOBEC3) and AID 
(mAID) were generated as N-terminal maltose binding protein fusion constructs. Although mAID 
was inactive under these conditions (data not shown), we had previously expressed and 
characterized active human AID (hAID) by co-expression of the enzyme with the chaperone 
Trigger Factor in E. coli (140).  Using this expression system, the full cohort of AID/APOBEC 
enzymes were all soluble and were partially purified over amylose resin as described in the 
materials and methods section.  
We designed DNA oligonucleotides containing a single cytosine residue with several 
criteria in mind [Figure 30A].  First, since each AID/APOBEC family member prefers to deaminate 
cytosine in a different trinucleotide sequence context (139), we selected a universal sequence 
that would be acted upon by multiple family members (S30-TGC). Next, a guanine was 
introduced directly downstream of the cytosine to create a CpG motif, an important consideration 
given that epigenetic modifications via methylation, hydroxymethylation and demethylation are 
highly linked to CpG sites and islands in the mammalian genome. 
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Figure 30: Substrate and assay design to screen for deamination of substrates containing 
5-modified cytosine.  (A) Fluorophore (FAM)-labeled oligonucleotides (S30) synthesized with a 
single internal modified cytosine (red) embedded in a CpG motif.  The preceding two bases, TG, 
provide a hotspot for deamination that is universally targeted by all AID/APOBEC family 
members.  (B) After incubation with deaminases, oligonucleotides were duplexed with a 
complementary strand generating U:G, T:G, or hmU:G mismatches with the deaminated 
substrates (blue). Treatment with UDG (reactive with U:G), TDG (reactive with T:G) or SMUG 
(reactive with hmU:G), respectively, followed by base-mediated cleavage leads to fragmentation 
of deaminated products to a 15-mer (P15).  
AID/APOBEC family members were assayed against the cytosine-containing substrate 
S30-TGC using a discontinuous, uracil DNA glycosylase (UDG)-coupled assay [Figure 30B]. At 
the end of the deamination period, the reaction product was hybridized to a complementary 
strand, yielding duplexed DNA containing a U:G mismatch in the deaminated product. Treatment 
with UDG generated abasic sites in the deaminated oligonucleotides, while leaving unreacted 
substrates intact. Cleavage of the abasic sites under alkaline conditions allowed for specific 
detection of product after separation on a denaturing gel.  To next examine the deamination 
activities on physiologically relevant 5-modified cytosines, we synthesized S30-TGmC and S30-
TGhmC.  Upon deamination, these substrates would convert to T and hmU, respectively. Since 
the coupling enzyme UDG is not active on either of these products, we needed to identify other 
glycosylase enzymes that would allow for excision of these products (171). Two useful enzymes 
for this purpose were TDG, which excised thymidine from T:G mismatches in CpG contexts, and 
SMUG, which excised hmU mispaired to G.  We established that these glycosylase-coupled 
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assays accurately detect low levels of deamination products by generation of a standard curve 
(as little as 0.5% product under the condition of our deamination reaction) [Figure 31]. 
	  
Figure 31: Detection limit and standard curve for deamination detection.  The calculated 
amount of substrate to product DNA is plotted against the actual amount, showing that the DNA 
glycosylases are useful for detection of low levels of deamination products. The dotted line 
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represents the theoretical maximum.  The limit of detection in a 100nM reaction is 0.5 nM 
deamination product.  The mean and standard deviation from 3-4 independent replicates are 
shown in the graph. 
Under these conditions the mAPOBEC1, mAPOBEC3 and hAID variants all showed 
deaminase activity against S30-TGC [Figure 32A].  As anticipated from prior studies mA2 showed 
no detectable cytosine deaminase activity (119).  Using the TDG-coupled assay, deamination of 
S30-TGmC was detectable with all active AID/APOBEC enzymes, though product formation was 
decreased relative to S30-TGC [Figure 32B].  By contrast, no detectable deamination activity was 
evident against S30-TGhmC [Figure 32C], despite robust deamination of S30-TGC under 
identical conditions with mAPOBEC1, mAPOBEC3 and hAID.  For the APOBEC2 deaminases, 
which have no known catalytic activity, but have been postulated to play a role in zebrafish 
demethylation (121), we found that mAPOBEC2 was also inactive against S30-TGmC or S30-
TGhmC in vitro.  
	  
C U
No 
Enzyme
C
mC T mC
hmC hmU hmC
!"
#$
%"
&'
()
*+
%"
&'
()
*,
%"
&'
()
*-
S30
S30
S30
P15
P15
P15
"
Substrate/
Glycosylase
S30-TGC
UDG
S30-TGmC
TDG
S30-TGhmC
SMUG
(
*
71	  
	  
Figure 32:	  AID/APOBEC enzymes preferentially deaminate unmodified cytosine. The 
reaction products resulting from 12 hour incubation of substrates (200 nM) with mA1, mA2, mA3 
or hAID (2 µM) are shown separated on a denaturing gel.  (A) S30-TGC substrates were assayed 
with UDG; (B) S30-TGmC substrates were assayed with TDG; (C) S30-TGhmC substrates were 
assayed with SMUG. 	  
To ensure that the discrimination against 5-substituted cytosine bases was not simply 
limited to a single sequence context, or perhaps the single enzyme concentration used in the 
above studies, we performed additional investigations. First, we tested a series of substrates 
containing C, mC and hmC in an ATX trinucleotide context, which is a preferred sequence for 
mAPOBEC1. As expected, reaction of S30-ATC with mA1 led to robust deamination, while S30-
ATmC was compromised and deamination of S30-AThmC was undetectable [Figure 33A].  When 
higher concentrations of mAPOBEC1 were employed, deamination of S30-ATC was nearly 
complete, while at the highest concentrations of mA1 only ~20% of the S30-ATmC was 
deaminated, and no deamination of S30-AThmC was ever detected (<0.5%). Deamination was 
observed to be linearly dependent on the amount of enzyme at lower mAPOBEC1 
concentrations, allowing the relative efficiencies for deamination of these substrates to be 
determined. Under these conditions, mAPOBEC1 was estimated to have ~10-fold discrimination 
against mC and >300-fold discrimination against hmC based on our detection limits.  
We utilized hAID bearing a truncation of the C-terminal region of (hAID-ΔC), which is 
associated with hyperactive deamination (~3-fold) without impacting sequence-dependent 
targeting35.  We reasoned that low-level deamination might be easier to detect with this 
hyperactive variant and employed it to evaluate the enzyme-dependence of deamination against 
the S30-TGX substrate series. As with mAPOBEC1, a similar discrimination against mC (~16-
fold) and significant discrimination against hmC (>150-fold) was found with hAID-ΔC [Figure 33B]. 
These results are not an artifact of studying the hyperactive enzyme, as a quantitatively similar 
pattern can be observed with full-length hAID [Figure 33C]. Finally, mAPOBEC3 also 
demonstrated clear discrimination against the naturally modified cytosine nucleobases [Figure 
33D], despite its distinctive canonical role from APOBEC1 and AID. We conclude that this strong 
discrimination against 5-substituted cytosines is an intrinsic property of the entire enzyme family 
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regardless of the source organism or canonical function. 
	  
Figure 33: Quantification of enzyme-dependent deamination of C-, mC-, and hmC-
containing substrates.  Total amount of deaminated substrates is plotted as a function of 
increasing concentrations of respective deaminases assayed against substrates (250 nM) 
containing a cytosine (red), mC (blue) or hmC (yellow).  (A) mAPOBEC1 was incubated with the 
S30-ATX series of substrates for 15 minutes.  (B) hAID-ΔC, (C) full-length hAID, and (D) 
mAPOBEC3 were incubated with the S30-TGX series of substrates for 12 hours. Substrates were 
assayed for deamination as described above (C:UDG; mC:TDG; hmC:SMUG). To account for 
incomplete cleavage of each product (U/T/hmU) by the respective glycosylase 
(UDG/TDG/SMUG), product formation was determined by quantification against a standard curve 
generated for each glycosylase [Figure 32]. Error bars represent standard deviation from at least 
three independent replicates. For relative comparison of substrates, the slope of each plot in the 
region where product formation is linear with enzyme (dashed line) is listed.  The values given for 
hmC substrates are the lower limits of detection with these substrates.	  
4.2.2 Deamination Decreases with Steric Bulk at C5 Position 
The molecular basis for recognition of cytosine by AID/APOBEC enzymes has been a 
matter of speculation given the lack of structural information on these enzymes complexed with 
nucleic acid substrates.  To probe the molecular impact of substitution at the 5-position of 
cytosine, we synthesized additional substrates with unnatural 5-substituents of varied steric and 
mAPOBEC1 (µM)
6.0
0
40
80
120
160
200
De
am
ina
tio
n 
Pr
od
uc
t (
nM
)
0.0 1.5 3.03.0
0
20
40
60
80
hAID-?C (µM)
0.0 0.5 1.51.0 2.0
De
am
ina
tio
n 
Pr
od
uc
t (
nM
)
nM product/
µM enzymeSubstrate
S30-ATC
S30-ATmC
S30-AThmC
67.8
7.6
< 0.2
nM product/
µM enzymeSubstrate
S30-TGC
S30-TGmC
S30-TGhmC
99.5
5.9
< 0.6
nM prod/
µM enzymeSubstrate
S30-TGC
S30-TGmC
S30-TGhmC
35.8
4.4
< 1
hAID (µM)
De
am
ina
tio
n 
Pr
od
uc
t (
nM
)
0.0 0.5 1.0
0
10
20
40
50
30
De
am
ina
tio
n 
Pr
od
uc
t (
nM
)
nM product/
µM enzymeSubstrate
S30-TGC
S30-TGmC
S30-TGhmC
37.6
6.8
< 0.3
mAPOBEC3 (µM)
0.0 1.5 3.0
0
25
50
75
100
125
! "
# $
73	  
	  
electronic character [Figure 34A] using a sequence context appropriate for focusing further on 
hAID-ΔC (S30-TGX) or mAPOBEC1 (S30-ATX). One potential determinant of reactivity in this 
series is the electron withdrawing ability of the C5-substituents. Electronegative C5 groups could 
potentially enhance deamination by making C4 of cytosine more electrophilic or by lowering the 
pKa of N3. Alternatively, hydrophobicity of the 5-position substituent could influence selectivity 
(188). Finally, the size of the substituent could dominate the rate effect with a ranked steric order 
of 5-H < 5-F < 5-OH < 5-methyl ~ 5-Br < 5-I ~ 5-hydroxymethyl. 
	  
Figure 34: Substrate and assay design for cytosines containing additional 5-substitutions.	  	  
(A) Substrate design.  Full complement of 5-subsituted cytosines.  (B) Screening of DNA 
glycosylases against natural and unnatural C5-modified cytosine and uracil.  Shown are the 
reaction products for each S30-TGC/S30-TGY substrate screened against each glycosylase and 
the no-enzyme control.  Qualitative summary of glycosylase activity on respective DNA 
substrates is also shown. Red indicates that a glycosylase is specific and active for the 
corresponding C5-modified uracil, but not the cytosine analog, making it potentially useful for 
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assays. The glycosylase selected for discriminating each modified cytosine bases from each 
modified uracil base is noted by bold outline. 	  
In order to study deamination of these unnatural cytosines, we first analyzed the activity 
of the coupling enzymes UDG, TDG and SMUG against DNA substrates containing either the 
modified cytosine or the corresponding 5-substituted uracil deamination product. Based on the 
determined substrate preferences, we selected to use UDG for the 5-fluoro substrates and SMUG 
for the 5-hydroxy, 5-bromo and 5-iodo substrates [Figure 34B].  The data corroborate the known 
studies on UDG, SMUG and TDG. In particular, UDG uses a steric discrimination mechanism that 
allows for excision of unmodified uracil and (5F)U, with some activity against (5OH)U. There is 
discrimination against cytosine bases through selective recognition of the uracil N2/C3 region 
through hydrogen bonding. By contrast, TDG excises bases in part through a mechanism that 
involves destabilization of the N-glycosidic bond. Thus, some excision activity is also seen with 
cytosine containing bases. SMUG has been previously shown to interact with uracil bases that 
have hydrogen bond donors at the 5-position.  
As was done for C, mC and hmC containing oligonucleotides, we constructed standard 
curves to allow for accurate quantification of deamination of each unnatural 5-modified substrate 
using our glycosylase-coupled assay [Figure 35]. 
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Figure 35: Standard curves show that DNA glycosylases are sensitive for detection of 
deamination of unnatural 5-modified cytosine substrates.	  	  The calculated amount of 
substrate to product DNA is plotted against the actual amount. The mean and standard deviation 
from 3-4 independent replicates are shown. These analyses confirm that UDG and SMUG are 
useful for detection of low levels of deamination products and allow for quantification of the true 
amount of deaminated product present based on the amount detected using the appropriate 
glycosylase. 	  
Each 5-substituted substrate was incubated with hAID-ΔC, then duplexed and treated 
with the appropriate glycosylase to assay for deamination. For hAID-ΔC, any substitution resulted 
in decreased efficiency of deamination relative to unmodified cytosine [Figure 36A].  To allow for 
relative comparison of substrates, we next calculated the product formation under conditions 
where deamination was linearly proportional to enzyme concentration [Figure 37A, C].  Across 
these series of substrates, representing a >150-fold difference in reactivity, the size of the 
substituent at the 5-position appeared to be an important determinant of deamination. The 
smallest unnatural substituent, S30-TG(5F)C, was deaminated most readily, although it remained 
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half as reactive as unmodified cytosine. Bulker halogen substituents were relatively poor 
substrates compared to the smaller mC. In addition to the influence of sterics, the poor 
hydrophobic character of hmC may play an additional role in the reactivity decrease seen 
between (5I)C, which has detectable deamination, and hmC, which has no detectable 
deamination. 
	  
Figure 26:	  DNA deamination decreases as a function of increasing steric bulk at the 5-
position of cytosine. (A) Incubation of hAID-ΔC with S30-TGX substrate series for 12 hours.  
Substrates are ordered by increasing steric bulk of the 5-substituent.  C and (5F)C substrates 
were assayed for deamination with UDG; mC substrates were assayed with TDG; and (5OH)C, 
(5Br)C, (5I)C and hmC were assayed with SMUG. The selection of the glycosylase used was 
based upon the survey of glycosylases [Figure 34].  (B) Incubation of mAPOBEC1 with S30-ATX 
substrates for 15 minutes.  (C) Incubation of mAPOBEC3 with S30-TGX substrates for 12 hours. 
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Figure 37: Quantification of enzyme-dependent deamination of 5-modified cytosines.	  	  
Quantification of enzyme-dependent deamination with (A) hAID-ΔC and (B) mA1. The amount of 
deaminated substrates plotted was a function of increasing concentrations of enzyme for 
mAPOBEC1 and hAID-ΔC, assayed against C- (red), mC- (blue), hmC- (yellow), (5F)C (green), 
(5OH)C (purple), (5Br)C (orange), and (5I)C (purple) containing substrates. Product formation 
was determined by quantification against a standard curve generated for each glycosylase 
[Figure 35]. Associated error bars represent standard deviation from at least three independent 
replicates and when not visualized are smaller than the symbol denoting the mean value. The 
data for C-, mC- and hmC- are the same as shown Figure 33, reproduced here to allow for 
comparisons to be made between substrates. (C) Shown are the electrostatic potential maps of 
each of the modified cytosine bases as determined using the SPARTAN program (6-31G* basis 
set). The electrostatic potential is colored from maximal negative (red) to positive (blue). The 
volume (*) is determined based on linking the 5-position substituent to a single hydrogen atom 
and calculating the total volume. The hydrophobic substituent constant (**) is derived from 
partitioning studies of substituted benzenes between octanol and water, where negative values 
for hydroxyl and hydroxymethyl substituents represent less hydrophobicity (Hansch C et al., J 
Med Chem, 1973, 16:1207-16).  Reported are the values for enzyme dependent product 
formation (nM product/µM enzyme) for each substrate examined with each active deaminases as 
reported in Figure 33 (†). The relative activity for each modified substrate when compared to 
unmodified cytosine for each deaminase is reported parenthetically, allowing for comparisons 
across a row with each enzyme. 	  
Nucleobase C (5F)C (5OH)C mC (5Br)C (5I)C hmC
Size* (Å3) 10.5 16.8 19.4 30.5 33.0 37.5 40.8
Hydrophobicity** 0.00 0.14 -0.67 0.56 0.86 1.12 -1.03
mAPOBEC1† 67.8 (1.0) 17.8 (0.26) 0.3 (0.005) 7.6 (0.11) 1.0 (0.015) 1.0 (0.015) <0.2 (<0.003)
mAPOBEC3† -37.6 (1.0) - - 6.8 (0.18) - <0.3 (<0.008)
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To assess the generality of reactivity determinants in the deaminase family, we 
additionally profiled mAPOBEC1 against a series of unnatural substrates in its preferred S30-ATX 
context [Figure 36B, 37B, C].  Again, 5-fluorocytosine was a good substrate for deamination, 
though approximately only one quarter as reactive as cytosine, while bulkier substituents were 
increasingly poor substrates. While smaller size remained a prerequisite for efficient deamination 
with mAPOBEC1, hydrophobicity also appears to play an important role. This is most strikingly 
notable with (5OH)C, which undergoes negligible deamination, while the larger mC is readily 
deaminated.  An additional qualitative assessment was made with mAPOBEC3 and its preferred 
S30-TGC substrate series [Figure 36C].  mAPOBEC3 displayed the same selectivity, with a 
notably increased discrimination against the (5OH)C substrate similar to mAPOBEC1.  Our 
extensive data show that for three distinct, active APOBEC family enzymes, efficient deamination 
of cytosine has steric requirements at the 5-position that contribute to the lack of any detectable 
enzymatic activity on hmC. 
4.2.3 Deaminases Do Not Perturb Levels of Modified Epigenetic Bases in Genomic DNA 
Among the multiple potential pathways for DNA demethylation, the possibility of 
collaboration between oxidation and deamination to generate hmU from mC has been postulated 
(38).  To complement our in vitro findings, we addressed whether deamination of hmC could be 
detected in genomic DNA. Accordingly, we overexpressed one isoform of the TET oxidase family, 
TET2, in HEK 293T cells, which the Zhang lab has previously demonstrated generates a high 
prevalence of genomic hmC in a genome that otherwise does not have detectable oxidized 
cytosine bases (14).  We then evaluated the impact of expression of individual AID/APOBEC 
enzymes on the levels of various modified nucleobases.  The additional candidate enzymes in 
demethylation, TDG and the individual AID/APOBEC family members, were each cloned and co-
transfected into HEK 293T cells along with TET2.  Similar levels of expression for each enzyme 
were confirmed by Western blot [Figure 38].   
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Figure 38: Protein expression of AID/APOBECs and TDG in HEK 293T cells. (A) Western 
blot showing co-expression of FLAG-tagged TET2, TDG, and AID/APOBEC1-3 in 293T cells. Top 
panel: FLAG-TET2 (212 kD) detected by the FLAG antibody. Middle panel: FLAG-TDG, AID, 
APOBEC1, APOBEC2 or APOBEC3 detected by the FLAG antibody in the same samples as the 
top panel. Bottom panel: α-tubulin levels as a loading control. (B) Western blot showing co-
expression of FLAG-tagged TET2 and untagged wild-type and mutant (E58A) hAID in HEK 293T 
cells. Top panel: FLAG-TET2 detected by the FLAG antibody. Middle panel: wild-type and mutant 
hAID detected by the AID antibody in the same samples as the top panel. Bottom panel: α-tubulin 
levels serve as a loading control.	  
Using methodology previously employed by the Zhang group to detect the products of 
iterative oxidation by TET (14), the genomic DNA was isolated and digested to generate a 
genomic nucleoside pool.  For highly sensitive detection of the modified bases, the obtained 
nucleosides were subjected to LC-MS/MS in multiple reaction-monitoring mode and quantified by 
comparison to known standards [Figure 39].  
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Figure 39: Effects of hAID expression on genomic levels of hmU, fC, caC in HEK 293T 
cells. Mass spectrometry traces are shown for hmU, fC, and caC along with 10 or 50 fmol 
standards. In the fC trace, peaks at 8.9 minutes and 10.9 minutes share similar mass but do not 
co-elute with authentic fC. In the hmU trace, 10 fmol produces a signal that is ~3 times above 
background. Compared with standards, the amount of hmU in 0.75 µg genomic DNA from cells 
overexpressing TET2 and hAID is below 10 fmol, while fC and caC are detected at levels above 
50 fmol.	  
As has been previously observed, TET2 overexpression in isolation leads to hmC levels 
that are about 1/6 that of genomic mC [Figure 40, blue bars].  The products of iterative oxidation, 
fC and caC, can also be detected at about 1/100 the level of mC.  We posited that if 
AID/APOBEC enzymes could deaminate hmC, three changes should be observed: hmU should 
be detected in genomic DNA, hmC levels should decrease, and fC/caC levels should also 
decrease due to the deamination of their precursor hmC.  However, none of these three predicted 
changes were observed when TET2 was overexpressed along with either mAPOBEC1 or hAID-
ΔC [Figure 40, green and black bars].  hmU was detectable in no conditions at all, despite the 
ready detection of an internal synthetic standard [Figure 39].  To further examine whether other 
family members might influence the genomic levels of modified bases, we screened all mouse 
AID/APOBEC enzymes and found no changes in the modified cytosine pools [Figure 40].   
By contrast to our results with overexpression of AID/APOBEC family members, we 
reasoned that if iterative oxidation coupled to BER is a feasible pathway for demethylation, levels 
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of modified cytosine bases should be readily perturbed by co-expression of TET and TDG. 
Indeed, we found that TDG overexpression led to dramatic reductions in the highly oxidized fC 
and caC species [Figure 40, magenta bars]. Despite depleting fC and caC, no overall change was 
observed in the levels of mC and hmC when TDG was overexpressed, likely as the highly 
oxidized species are far less prevalent that mC and hmC. This observation additionally suggests 
that TDG-mediated depletion of fC and caC does not promote further oxidation and consumption 
of genomic hmC.  Potential explanations include the possibility that some genomic hmC is 
sheltered from further oxidation or plays roles independent of demethylation (65).  While the 
dynamics of iterative oxidation will require further intensive study, from our data we conclude that 
the prevalence of modified cytosine nucleobases in the genome can be altered by overexpression 
of the players in the deamination-independent pathway, but not by those in the deamination-
dependent pathway. 
	  
Figure 40:	  Deamination intermediates of oxidized cytosine are not detected in genomic 
DNA. Genomic DNA was extracted from HEK 293T cells co-expressing TET2 and TDG, 
AID/APOBEC1-3, wild-type or mutant hAID. Total amounts of mC, hmC, fC, caC, and hmU are 
graphed in fmol, as grouped by individual base.  Asterisks: p ≤ 10-3 for fC and caC in samples 
with TDG in comparison to plasmid only control.	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The inability to detect hmU required additional controls to confirm that hmC was not being 
deaminated and then rapidly excised from the genome.  First, we determined whether our inability 
to detect hmU could be due to its rapid enzymatic excision from the genome. To test this 
question, we isolated nuclear extracts from 293T cells and tested the hmU excision activity of the 
lysates against uracil-containing DNA substrates.  We observed negligible hmU excision activity 
under conditions where robust nuclear uracil glycosylase activity was observed [Figure 41].  The 
results demonstrate that hmU glycosylase activity in HEK 293T cells is limited and quantitatively 
at least 400-fold less than uracil excision activity.  Together these data suggest that if 
deamination of hmC occurs, the deaminated lesion is not being rapidly excised from the genome.  
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Figure 41: Uracil and not hmU is rapidly excised by HEK 293T cell nuclear extracts.  (A) To 
analyze the endogenous glycosylase activity for uracil and hmU in nuclear lysates, duplexed S30-
TGY (Y = U or hmU) substrates were incubated in the presence or absence of nuclear lysates for 
up to 45 minutes before reactions were quenched. (B) The reaction products were visualized on 
denaturing polyacrylamide gel and shown is a representative denaturing gel with time points. The 
gel demonstrates rapid uracil excision, with relatively less excision of hmU. (C) To quantitatively 
analyze product formation from the reactions in part B, the reactions were performed in triplicate 
and quantified as described for deamination reactions. Shown is the calculated amount of uracil 
or 5-hydroxymethyluracil bases excised per µg of nuclear lysates plotted as a function of time. 
Error bars represent standard deviation. The specific uracil glycosylase activity in HEK 293T 
nuclear lysates was calculated as the linear slope associated with data collected at < 1 min, given 
its rapid excision. The linear fit across all data collected with hmU yields the specific hmU 
glycosylase activity. 	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Next, to confirm that the overexpressed deaminases were active in the nucleus, we first 
examined nuclear lysates for deaminase activity using oligonucleotides containing unmodified 
cytosine.  To determine whether AID and APOBEC1 are catalytically active in the nucleus of 
293T cells, deaminase assays were performed with single stranded S30-TGC (for hAID-ΔC) and 
S30-ATC (for mAPOBEC1).  If deamination occurs, uracil is excised by UDG in the nuclear 
extracts, leaving abasic sites to be cleaved by base treatment. TET2-AID nuclear extracts and 
negative controls (no extract, nuclear extract from untransfected 293T cells, and TET2-AID E58A) 
were incubated with nucleic acid substrates and analyzed by denaturing PAGE.  Nuclear extracts 
were also incubated with a uracil-containing substrate to verify that 293T nuclear extracts have 
robust uracil excision activity. TET2-APOBEC1 nuclear extracts and negative controls (no extract 
and nuclear extract from untransfected 293T cells) were incubated S30-ATC or with the product 
control S30-ATU. In line with our biochemical studies, deamination of cytosine was only 
detectable in nuclear lysates from cells overexpressing either hAID-ΔC or mAPOBEC1 [Figure 
42].  Importantly, this activity is dependent on catalysis, as no deaminase activity was seen in 
nuclear extracts from cells overexpressing a catalytic mutant of hAID (E58A).   
	  
Figure 42: Overexpressed hAID-ΔC and mAPOBEC1 are active in deamination in nuclear 
extracts. Nuclear extracts from transfected 293T cells were incubated with single stranded S30-
TGC (for hAID-ΔC) and S30-ATC (for mAPOBEC1) for a total of 30 minutes.  Endogenous UDG 
within lysates cleaves uracil and generates abasic sites for base treatment.  The sample 
demonstrating deamination of the S30-TGC in TET2-AID extracts is highlighted (red).  The 
sample demonstrating deamination of the S30-ATC substrate in TET2-mAPOBEC1 extracts is 
highlighted (red).	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As a second validation of deaminase activity in the cellular setting, we examined whether 
overexpressed deaminases have an appreciable impact on genomic deoxyuridine (dU) levels.  To 
overcome the rapid and efficient processing of genomic dU by multiple DNA repair pathways, we 
aimed to inhibit the major pathway involving UDG by overexpressing the small protein uracil DNA 
glycosylase inhibitor (UGI) (171) along with hAID, hAID-E58A, mAPOBEC1 or an empty plasmid 
control [Figure 43A].  The nuclear lysates associated with UGI overexpression were unable to 
excise uracil from duplexed oligonucleotides, demonstrating that UGI effectively inhibits one 
important pathway for uracil excision [Figure 43B].  We quantified the level of genomic dU using 
our highly sensitive LC-MS/MS methodology, and demonstrated a consistent increase in genomic 
dU in hAID samples relative to hAID-E58A or the empty plasmid control [Figure 43C].  Unlike 
hAID, it is unknown if mAPOBEC1 can act upon genomic cytosine.  Compared to an empty vector 
control, we saw a trend towards increased genomic dU with mAPOBEC1 overexpression.  Thus, 
by two measures, in lysates and through analysis of genomic DNA, the deaminases appear to be 
active on unmodified cytosine under conditions where no deamination of hmC is detectable.  
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Figure 43: Overexpressed hAID and mAPOBEC1 are active in deamination. (A) UGI 
expression does not alter DNA deaminase expression. Cell lysates were subjected to SDS-PAGE 
and western blotting to analyze expression of the proteins. Top panel: hAID and hAID(E58A) 
detected by α-AID antibody; FLAG-APOBEC1 detected by the α-FLAG antibody. Bottom panel: 
α-tubulin levels as a control for equal loading.  (B) To confirm that UGI is active in the conditions 
used for mass spectrometry experiments and inhibits uracil excision, nuclear lysates from cells 
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transfected with UGI-pIRES or an empty-vector control (pIRES) were incubated with uracil 
substrates.  Unreacted substrates are denoted by S30 and cleaved product by P15.  (C) UGI and 
hAID or mAPOBEC1 co-expression result in an increase in genomic uracil.  Genomic DNA was 
extracted from HEK 293T cells co-expressing pIRES control or UGI-pIRES along with an empty 
vector control, hAID, hAID(E58A), or mAPOBEC1.  The absolute amount of dU nucleoside was 
normalized to the absolute amount of deoxycytosine. The mean values are plotted with error bars 
from two to four independent replicates shown with p-values from unpaired t-test shown. 
4.3 Discussion	  
4.3.1 Re-evaluation of Deamination-Dependent Demethylation Pathways 
We can now reconcile the enzymatic characteristics of the AID/APOBEC deaminases 
determined here with their proposed function in the early steps of proposed DNA demethylation 
pathway.  This is best accomplished by appraising the multiple discrimination mechanisms 
utilized by these deaminases to target their DNA substrate.  At the level of the nucleobase, these 
deaminase enzymes have all evolved an active site that is designed to deaminate unmodified 
cytosine preferentially. However, deamination of mC to T can occur, albeit at ~10-fold reduced 
rate relative to cytosine deamination. Thus, strictly from the perspective of biochemical feasibility, 
deamination of mC may constitute a viable pathway for demethylation in some situations, though 
other constraints are important to consider (see below). By contrast, we demonstrate that no 
deamination of hmC was detectable in vitro or in cells when relevant enzymes were 
overexpressed.  Our results contrast with those of a prior study that used immunoblotting of DNA, 
a method of uncertain specificity, to report detection of genomic hmU (38).  However, our findings 
are in good agreement with studies on embryonic stem cells, where hmU was not detectable in 
genomic DNA when probed with a sensitive and specific mass spectrometry methodology (60, 
78).  There is a recent published report of hmU, detected in both mouse and human tissues 
(189).  However, the levels of this base were modestly affected by TET1 overexpression, unlike 
hmC, fC and caC, which all saw marked increases.  If hmU truly is produced at low levels during 
TET1 expression, it is possible that it may be derived from off-target oxidation of thymine rather 
than hmC deamination.  Together, our biochemical and cellular data provide a strong argument 
against the proposed collaboration between oxidation, deamination and BER as a pathway for 
DNA demethylation in mammalian cells. 
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At the next level beyond the target cytosine, the local sequence context provides an 
additional potential barrier to efficient deamination. Each AID/APOBEC family member is known 
to act at preferred trinucleotide hotspots (139), yet methylated CpG motifs can be found in all 
common sequence contexts, even those that may be disfavored by the individual deaminases. 
For AID, guanine is the least favored nucleotide downstream of the target cytosine, making the 
physiologically relevant CpG motif a non-ideal substrate for deamination, regardless of the 5-
substituent (140). 	  
Since all known AID/APOBEC enzymes are specific for single-stranded DNA (16, 164), it 
remains unclear how methylated CpG motifs in genomic DNA might be sufficiently targeted by 
AID/APOBECs.  Although transcription or replication could generate single-stranded DNA, active 
demethylation of CpG islands does not necessarily require replication or transcription (54, 55).  
Further, only AID and human A3A have been shown to deaminate mammalian host genomic 
DNA (100, 131, 134), and these mutations appear to be localized to expressed genes.  Within 
Peyer’s patch B-cells, where AID expression is high, preferred deamination at the 
immunoglobulin locus occurs >25 times more frequently than the next most targeted locus, and 
unexpressed genes are not mutated by AID. Finally, expression of the various deaminase family 
members is often restricted to particular cell lineages or tissue types, suggesting that a single 
deaminase is unlikely to play a universal role in demethylation.  For example, detectable 
expression of AID and APOBEC1 has been reported in stem cells, but not of APOBEC3, limiting 
the potential players in maintenance of pluripotency in these cells (183). 	  
Integrating across these layers of targeting, from the nucleobase to the cellular level, 
enables us to assess the plausibility of the early steps in the various proposed DNA 
demethylation pathways.  First, our findings show that deamination of mC remains a plausible 
demethylation pathway based on enzymatic function, although other known limitations in 
targeting would seem to present several barriers to its efficient function.  It is possible that 
deamination of mC operates in non-physiological systems, such as heterokaryon-based 
reprogramming (185).  To this point, two separate groups have reported a potential role for AID in 
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the reprogramming of induced pluripotent stem cells (190, 191).  However, these studies rely 
heavily on fibroblasts from AID knockout mice.  In the mouse genome, AID is located in close 
proximity to Nanog and other factors associated with pluripotency (192).  Therefore, it cannot be 
excluded that knocking out AID may also remove an enhancer, noncoding RNA, or some other 
genomic element that may contribute to expression of nearby pluripotency genes. 
In other physiological settings, it will be important to examine whether unidentified post-
translational modifications or cellular factors can facilitate deaminase targeting to CpGs in specific 
methylated promoters, allowing these enzymes to play a role in particular niches.  Although our 
findings exclude hmC deamination as a detectable enzymatic activity, a requirement for 
AID/APOBEC enzymes in conversion of hmC to C in neurons has been previously suggested 
(38). Notably, in that study, AID/APOBEC enzymes were not shown to be directly capable of hmC 
deamination, and a requirement for catalytically active AID in conversion of hmC to C was also 
not established. If catalysis were to be required, it is feasible that AID/APOBEC-mediated 
deamination of C or mC indirectly stimulates TET or DNA damage response pathways to promote 
excision of genomic hmC.  Our biochemical and cellular data make it unlikely that deamination of 
hmC by AID/APOBEC enzymes is involved in DNA demethylation. 
4.3.2 Re-evaluation of Potential Pathways for DNA Demethylation 
 Our biochemical results allow us to clarify the proposed pathways of DNA demethylation.  
With regards to the deamination-dependent pathways, we conclude that oxidation-coupled 
deamination is not a viable pathway towards the regeneration of demethylated cytosine.  We 
arrive at this conclusion from the lack of deaminase reactivity against hmC, assessed in multiple 
contexts.  Deamination-dependent demethylation remains a viable pathway when mC is the initial 
substrate.  However, the reduced rate of deamination when compared to unmodified cytosine 
presents an intrinsic kinetic barrier that limits its demethylation potential.   
In raising doubtful concerns regarding deamination-dependent demethylation, our 
findings shift the focus in favor of oxidation-dependent, deamination independent DNA 
demethylation.  Under the very same conditions of cellular overexpression where the product of 
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hmC deamination (hmU) is not observed, the proposed intermediates in the iterative-oxidation 
pathway, fC and caC, were readily detected.  There are many important biochemical questions 
that currently remain unanswered regarding the mechanisms of action of the TET family.  First 
and foremost is the urgent question of the relative rates of oxidation of mC, hmC, and fC.  As 
hmC is the most abundant oxidized cytosine base, it remains to be determined whether iterative 
oxidation is a rate-limiting step in DNA demethylation.  Given that the kinetics of fC and caC 
excision by TDG have already been described, determination of the rates of oxidation will 
illuminate whether production of oxidized bases may outpace their removal from the genome.  
Further questions, such as sequence specific targeting of DNA, will inform biological studies of 
the TET enzymes, and exploration of the oxidation-dependent pathway will continue to demystify 
the mechanisms of DNA demethylation. 
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CHAPTER 5: Conclusions and Future Directions 
 The studies within this thesis have sought to illuminate aspects of the deamination 
reaction of AID and its fellow APOBEC homologs for the purpose of clarifying their contributions 
to biology.  Two particular areas have been explored: the selectivity for DNA over RNA, and the 
tolerance of modified cytosine substrates implicated in DNA demethylation.  We have found that 
the preferred substrate for AID is unmodified, 2’-deoxycytosine.  Modification at the 5-position of 
the base creates steric bulk that disfavors deamination, while modification at the 2’-position of the 
sugar creates a disfavored sugar pucker.  The implications for DNA demethylation and the DNA 
deamination model of antibody maturation have been discussed in previous sections and will not 
be revisited here.  Instead, the focus of this discussion will shift to a consolidation of our 
biochemical observations into a unifying model of substrate recognition and open questions for 
further study of AID/APOBEC-mediated deamination. 
5.1 Model for Substrate Recognition and Deamination by AID 
5.1.1 Description of Model 
 Our findings of the nucleic acid determinants of deamination support the following model 
for substrate recognition by AID/APOBEC deaminases, consistent with current biochemical, 
structural, and single-molecule studies [Figure 44] (137, 140, 145, 146, 193).  The model focuses 
on AID, as this deaminase served as the focus of the studies described within. 
The process of deamination initiates when AID binds non-specifically to the substrate 
backbone with a high affinity.  Subsequently, the enzyme scans along single-stranded patches of 
DNA and ceases scanning as it interrogates the local base content for the presence of hotspot 
targets.  Permissive sugar puckers in a DNA-like conformation, dictated by the 2'-substituents at 
the -2, -1 and 0 positions within the hotspot, stabilize the enzyme-substrate complex through the 
facilitation of hydrogen bonding and base-stacking interactions.  This step is consistent with our 
experiments on chimeric 2’-F-RNA substrates.  We observed that removal of the 2’-F groups from 
the -2, -1 and target positions was required for rescuing AID’s deaminase activity against the 
otherwise disfavored substrate.   
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With the substrate firmly docked to the enzyme, conformational flexibility is required of 
the target cytosine so that it may twist out of register with neighboring nucleotides and enter the 
enzyme active site.  This conformational flexibility is conferred by the ability of the target 
nucleotide sugar to interconvert between its two dominant conformational sugar puckers: C2’-
endo and C3’-endo.  The importance of this conformational flexibility is highlighted by our results 
regarding AID’s reactivity against chimeric DNA substrates.  The DNA substrates that contained 
cytosine conformers with a strict C3’-endo sugar pucker were significantly disfavored for 
deamination—up to 500-fold worse than the ideal, fully DNA substrate.  By contrast, the 
substrates containing cytosine conformers that preferred the C2’-endo conformation were readily 
deaminated, indicating the importance of this sugar pucker as a permissive conformation for 
deamination.  Most notably, the most deamination was observed with the substrate containing 2’-
deoxycytidine.  While this conformer prefers the C2’-endo state, it is distinguished from the rest of 
the assayed conformers in that it shows the greatest ability to interconvert between the C2’-endo 
and C3’-endo states, as determined by NMR spectrometry.  The optimal reactivity of substrates 
with 2’-deoxycytidine, contrasted with substrates containing other conformers, suggests the 
importance of nucleotide flexibility in AID-mediated deamination. 
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Figure 44:  Mechanistic model for nucleic acid targeting and selectivity.  Upon AID binding 
to its hotspot WRC target (W = A/T, R = A/G), a preferred C(2')-endo conformation from -2 to 0 
facilitates productive active site interactions, which can be antagonized by a single C(3')-endo-
promoting substituent at the target nucleotide.	  
Once cytosine enters the deaminase active site, proper fit of the base is necessary to 
ensure efficient deamination.  Modification of cytosine at the 5-position of the base, such as 
methylation or hydroxymethylation—provides a steric clash with the boundaries of the active site, 
displacing the base and preventing is proper reactivity for deamination.  Lacking any 
modifications at the 5-position, unmodified cytosine is able to enter the active site, free from steric 
interactions with the sides of the active site, and readily undergo deamination given its proper 
positioning.  This aspect of the model is supported by our observation of AID’s reactivity with a 
series of substrates in which there was an inverse correlation between the size of the 5-
substituent and reactivity for deamination.   
Though the data in support of this model was primarily obtained with AID, additional 
experiments with other members of the APOBEC family give us the confidence to conclude that 
!"#$%&'()*+",*-./%+,-012+3-45'2
6'4',,127+8*2+'88949'(.+)'1:9(1.9*(
!";$%&'()*+"(*2./%+,-012+3-45'2
<-88949'(.+.*++)9,2-3.+)'1:9(1.9*(
=>?
@&#
A
A
@&B
P
O
C
D
A !
3!-O
=4.9E'
,9.'
=>?
=4.9E'
,9.'
A
A
F
PO
O
O-
A
A
F
C
D
PO
O A
AF
3!-O
5!-O
5!-O
O
=>?
A
A
P
O
O-
A
A
PO
O
O-
C
D
A
@G !
3!-O
=4.9E'
,9.'
5!-O
O
=>?
A
A
@&#
P
O
O-
A
A
@&B
PO
O
!"#$%!"&$%!'(%") !'(%"*)
H
*,
9.9
*(
&#
&B
G
!
@&B
@&#
F
94	  
	  
the model likely applies across the family.  With regards to base modifications, AID, APOBEC1, 
and APOBEC3 all demonstrated a preference for unmodified cytosine over 5-methylcytosine, with 
no detectable deamination of 5-hydroxymethylcytosine.  Not only were the relative preferences 
for these bases conserved across the deaminases, but also all three enzymes showed a similar 
pattern of discrimination against the size of the modifying group at the 5-position.  Regarding the 
importance of the nucleotide sugar pucker at the target cytosine, AID and APOBEC1 share an 
inherent preference for DNA over RNA.  The conservation of the molecular determinants of the 
nucleotide sugar and the 5-position of the base suggests that the core aspects of the deamination 
reaction remain conserved across the entire AID/APOBEC deaminase family since their 
evolutionary divergence.  Thus, our model for deamination is likely broadly applicable to other 
family members. 
5.1.2 Remaining Questions Regarding Deamination Model 
 While our model of deamination clarifies certain aspects of the AID/APOBEC 
deamination reaction, there are two unexplained areas that will require further study.  The first 
question is how sequence-specific deamination may emerge from non-specific nucleic acid 
binding.  This question develops out of the observation that AID binds to its nucleic acid 
substrates with a high affinity (Kd ~10 nM) and no known sequence specificity, yet deamination 
occurs at ‘hotspots’ with a greater frequency that other ‘coldspots’.  One natural hypothesis is that 
hotspot motifs have more favorable hydrogen bonding interactions with the hotspot targeting loop.  
Thus, during scanning, the enzyme would be more likely to pause at hotspot motifs, providing the 
cytosine nucleotide a greater likelihood of entering the enzyme active site for deamination. 
 There are several techniques that could be leveraged to answer this interesting question.  
The technique best suited to answering this question is single-molecule microscopy.  This 
technique has already been employed collaboratively by the Goodman and Rueda laboratories to 
explore the scanning characteristics of A3G (193).  Notably, this previous study demonstrated 
that A3G may spent up to 10 minutes bound to the same strand of DNA before releasing, while 
catalyzing only a handful of deaminations.  This technique is largely enabled by advances in 
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protein labeling, namely the conjugation of fluorescent dyes to the enzyme that permit 
visualization of individual monomers by fluorescent microscopy.  Specifically, the expression of 
AID as a fusion protein to a large scaffold such as MBP or GST allows the scaffold to be 
engineered without significantly affecting the overall protein stability.  The design of substrate 
DNA with fluorescent probes strategically located in hotspots or coldspots would provide a 
method by which to investigate the scanning occupancy at the different motifs.  Ultimately, this 
line of analysis could reveal the contributions of scanning to the overall deamination reaction. 
 This question of scanning opens up a larger question of tremendous significance: what is 
the structural basis for substrate recognition and deamination?  Answering this question through 
structural characterization of a DNA-bound crystal structure could provide several important 
insights.  First and foremost, this structural information would provide the high-resolution 
information needed to test our proposed model of deamination.  We have done our best to 
describe the determinants of deamination using mechanistic biochemistry, but this is no match for 
a crystal structure that would describe determinants of the enzyme-substrate complex.  Beyond 
the validation of our proposed model, structural information would aid in inhibitor design, with 
implications for exploration of the biology and kinetics of deamination.  
 To date, AID has been refractory to structural characterization despite efforts from 
several groups.  While other members of the APOBEC family have been described using X-Ray 
crystallography and NMR spectroscopy, none of these structures have been described in the 
presence of a bound nucleic acid.  The difficulties in achieving a successful structural 
characterization largely stem from the poor solubility of AID and other APOBEC family members.  
Additionally, the nucleic acid binding properties of these enzymes result in purifications of soluble 
aggregates that are quite heterogeneous.  The many impurities in these solutions pose an 
additional problem towards achieving a structure.  Thus, there are significant impediments that 
currently preclude a clear picture of what AID/APOBECs look like as they deaminate their 
substrates. 
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 While AID and its fellow APOBECs have proved refractory to structural characterization, 
our results provide insights that may illuminate a potential experimental strategy.  Disulfide cross-
linking technology may be used to trap complexes of AID/APOBECs bound to DNA, generating 
an intermolecular adduct between enzyme and substrate (194).  This technology, developed by 
Verdine and colleagues, would involve two unique modifications, one occurring on the substrate, 
the other occurring on the enzyme.  The first modification involves the introduction of a thiol 
modification on the DNA substrate.  The second modification involves engineering a strategic 
cysteine residue into the enzyme.  If the engineered cysteine on the enzyme is in close proximity 
to the free thiol on the substrate, the two may form a disulfide cross-link that permits enrichment 
of a highly-specific enzyme-substrate complex. 
 A similar approach may be taken to trap a member of the AID/APOBEC family with a 
hotspot targeting motif engaged by a DNA substrate.  Our results with the 2’-F RNA substrates 
demonstrated that removing the 2’-F substituents from the -2, -1, and 0 positions relative to the 
target cytosine could rescue deamination.  This mechanistic observation suggests that sequence 
specificity of deamination may stem from hydrogen bonding and base stacking between the 
hotspot loop and these residues.  A thiol group engineered into the -2 or -1 positions may be able 
to cross-link with a cysteine residue, strategically engineered into the hotspot targeting loop.  
Ongoing work in the Kohli lab using deep positional mutagenesis of the hotspot targeting loop has 
revealed amino acid positions that are amenable to cysteine substitution, preserving enzymatic 
activity.  These results could be used to design a strategy for structural characterization of AID 
trapped to its nucleic acid substrate. 
 A potential experimental complication may arise from AID’s tight binding affinity to single-
stranded DNA.  With dissociation constants in the low nanomolar range for AID and most other 
APOBEC family members, non-specific interactions are likely to be enriched.  For X-Ray 
crystallography, a highly pure, homogeneous crystal is required to generate a coherent diffraction 
pattern.  In this regard, it may be necessary to turn to A3A, a unique member of the AID/APOBEC 
family for its weak binding affinity.  Reports suggest that A3A has a dissociation constant between 
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10-50 µM (151, 152).  This is approximately 1000 times worse than other members of the 
AID/APOBEC family, indicating very weak binding affinity for substrate and low likelihood of 
enriching non-specific binding interactions.  However, the presence of an intermolecular disulfide 
cross-link between A3A and its nucleic acid substrates could result in enrichment of highly-
specific interactions between enzyme and substrate, providing a method for obtainment of 
homogeneous crystals for further study. 
 One potential concern about the structural studies of A3A is the applicability to the larger 
AID/APOBEC family.  A3A has established itself as somewhat of an outlier within the 
AID/APOBEC family in two regards.  First, A3A demonstrates weak binding affinity towards its 
DNA substrates, as described above.  This means that A3A may contact the phosphodiester 
backbone or individual bases in a unique manner that does not represent the mechanisms of 
interaction for its homologs.  While such a finding would still be of interest, as it would cast light 
on the mechanisms of substrate recognition for A3A, but further studies would be needed to 
determine the applicability to AID and the rest of the APOBEC family.  Additionally, A3A 
demonstrates a catalytic efficiency that is several orders of magnitude greater than its 
AID/APOBEC homologs.  It is certainly possible that this uniquely increased catalytic activity is 
connected to decreased binding affinity, particularly if end-product release is a rate-limiting step in 
turnover for deamination.  Nevertheless, hypotheses for future structure-function analysis of AID 
and the APOBEC family.  While structural studies of A3A may not reveal universal aspects 
regarding AID/APOBEC cytosine deamination, they would provide a beneficial starting point for 
future studies on the rest of the enzyme family. 
5.2 Future Biochemical Studies of Deamination 
5.2.1 Further Studies of DNA Deamination with A3A 
 While our studies have demonstrated the general properties of deamination, quantitative 
rigor has been lacking.  The basis of our quantitative measurements—the observation of a linear 
relationship between product formation and enzyme concentration at fixed, 12 hour deaminase 
incubations—does not provide traditional measures of catalytic efficiency or substrate affinity.   
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 The robust catalytic activity of A3A makes it well-suited for proper kinetic assessment of 
the questions addressed within the body of this thesis.  Previous biochemical characterization of 
the enzyme suggests that it is capable of multiple turnover events within a few minutes (151, 
152).  This contrasts with the conditions of our deaminase assays with other enzymes, in which 
single-turnover kinetics were observed with an excess of enzyme compared to substrate.  A3A 
may support the collection of proper kinetic measures, including kcat and KM, that will 
communicate a more standard reference of enzymatic activity and proper evaluation of relative 
preferences. 
 The greater catalytic efficiency of A3A may allow us to re-examine the substrates in this 
thesis that were disfavored for deamination.  In examining the role of base or sugar modifications, 
AID’s poor deaminase activity served as an impediment with regards to obtaining accurate, 
quantitative preferences for each substrate.  It was necessary to establish a lower limit of 
detection for the most poorly reactive species—hmC and D-rC—which was then compared to the 
modest deaminase activity against the ideal substrate in order to establish a relative preference.  
In all cases, the limited deaminase activity hampered our ability discern the true degree of 
discrimination against disfavored substrates, creating a need for a deaminase with increased 
activity.  One aspect of our conclusions is the conservation of these determinants of deamination 
across the active members of the AID/APOBEC family, allowing us to predict with a high degree 
of certainty that A3A would also display the same pattern of preferences.  Given A3A’s robust 
DNA deaminase activity, repeating our experimental analyses with this deaminase may enable us 
to achieve a more accurate estimate of selectivity against hmC and the D-rC substrates.  Even if 
these substrates remain non-reactive, normalization of our lower limits of detection to an 
increased default rate of deamination would more accurate measures of selectivity and bolster 
the confidence of our findings.  
5.2.2 Future Biochemical Studies with Chimeric Deaminases 
 A3A also provides a handle for further study of the various properties of the enzyme that 
confer deaminase activity and define the protein determinants of catalytic activity.  This potential 
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is best illustrated by studies of the hotspot targeting loop that confers sequence-specific 
deamination.  The role of this loop in deaminase targeting has been demonstrated by several 
groups using both cellular and biochemical studies of AID.  These initial studies have shown that 
A3G sequence-specific deamination can be conferred to AID by engraftment of the A3G hotspot 
targeting loop (140, 145, 146).  However, this chimeric enzyme remains poorly characterized, in 
large part due to the poor baseline deaminase activity of AID.   
 Initial studies of an AID-A3A chimera indicate a more active form of AID that may be 
more tractable towards biochemical characterization.  With regards to the proposed roles of AID 
in DNA demethylation, the Bhagwat group devised a Kanamycin selection assay within E. coli to 
screen for deamination of methylated cytosines (195).  They evaluated AID and A3A with this 
assay and found that AID was weakly reactive with mC and A3A strongly reactive.  Then, to 
determine whether the A3A targeting hotspot loop could augment AID’s mC deaminase activity, 
they tested an AID-A3A Loop (AID-3AL) chimera and found increased levels of mC deamination, 
relative to the ordinary AID control.  This result indicates the importance of the hotspot loop as a 
potential enzymatic determinant of selectivity for cytosine methylation. 
 However, much remains to be elucidated from this study, as the proper controls were not 
performed.  Particularly, the study by Bhagwat and colleagues did not determine whether the 
increase in mC deaminase activity of the AID-3AL variant was due to non-selectively increased 
overall deaminase activity, decreased discrimination of mC relative to C, or a combination of the 
two.  Had the authors desired to ask this question using their bacterial mutagenesis selection 
assays, they could have repeated their findings with a Rifampin mutagenesis assay, which 
interrogates levels of unmodified C deamination.  This measure could be used to normalize the 
mC deaminase activities of each enzyme and determine whether AID and A3A share the same 
relative tolerance of mC and, if not, whether the AID-3AL variant behaves more like AID or A3A. 
 This question may now be easily assessed using the in vitro biochemical approaches 
utilized in chapter 4 of this thesis.  The AID-3AL variant may now be purified, and assessment of 
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the discrimination profile against the full panel of 5-modified cytosines may inform the contribution 
of the hotspot loop to mC/hmC deamination selectivity.   
A3A may also serve as a recipient for engraftment of the hotspot loop from AID and other 
APOBECs.  The great advantage of this approach is that A3A has much greater enzymatic 
activity.  Therefore, modifications that reduce overall deaminase may still be detected, given the 
significant baseline activity of A3A.  The same cannot be said for AID, for which marginal 
enzymatic activity is only observed at a vast excess of enzyme relative to substrate.  This situates 
A3A as an ideal enzyme for observing a larger number of potential chimeric variants. 
Initial efforts in the lab have successfully yielded an A3A-A3G Loop variant (A3A-3GL) 
that retains robust deaminase activity (Data not shown).  This variant has been screened against 
a panel of 5-substituted cytosines to reveal its preferences and determine whether the 
preferences of this variant align with the donor enzyme (A3A) or the engrafted loop (A3G).  
Tentative results indicate that selectivity segregates with the engrafted loop rather than the donor 
enzyme, suggesting that the hotspot loop may interface with part of the enzyme active site.  This 
will be an ongoing area of investigation, providing further mechanistic insights into the 
determinants of the deaminase reactions in the absence of a nucleic acid-bound crystal structure. 
Expanding beyond the hotspot targeting loop, an additional aspect of the AID/APOBEC 
family may serve as ideal targets for future chimera studies.  Similar to the hotspot targeting loop, 
there is an additional loop that was identified as a candidate for interaction with nucleic acid 
substrates, heretofore referred to as the accessory loop (146).  This loop was first identified 
based on the crystal structure of the catalytic domain of A3G.  If the hotspot loop is predicted to 
interact with the -2 and -1 positions of target DNA, the accessory loop is predicted to interact with 
the +1 position.  The accessory loop has not been extensively studied, but a report from the 
Bhagwat group demonstrated that engraftment of both the accessory loop and hotspot targeting 
loop from A3G into AID boosted A3G-specific deaminase targeting over chimeric containing just 
the hotspot targeting loop alone.  Modeling studies with the recently-solved NMR structure of A3A 
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similarly predict an interaction between the DNA substrate and the accessory loop, and further 
study is merited (138). 
5.3 Future Cellular Studies of Deamination 
The most pressing questions regarding the AID/APOBEC family regard established and 
emerging roles in DNA damage and demethylation.  With regards to DNA damage, the recent 
implication of A3B as a driver of mutagenesis in breast cancer adds to the established body of 
evidence regarding AID’s pro-mutagenic effects.  The possibility remains that other APOBECs, 
such as A3A, may contribute to mutagenesis as well.  With regards to DNA demethylation, it 
appears that AID may have a niche role in the reprogramming of induced pluripotent stem (iPS) 
cells (190, 191).  Given these new biological roles for the AID/APOBEC family, outside the 
traditional scope of adaptive and innate immunity, cellular studies are needed to further evaluate 
the validity of these claims.  Our biochemical insights can be leveraged to add to this body of 
knowledge and evaluate hypotheses in a cellular setting, testing the novel proposed functions of 
the family. 
5.3.1 Evaluation of Proposed Role of AID in Reprogramming of iPS Cells 
 The proposed role of AID/APOBECs in DNA demethylation has been discussed in depth 
in chapter 4.  Our results indicate an unlikely role for hmC deamination as a route to DNA 
demethylation given the lack of any reactivity across the family.  However, the weak reactivity of 
AID and other APOBECs against mC indicates that this DNA demethylation pathway is possible, 
though subject to an intrinsic kinetic barrier.  This information can be used to expand upon the 
observations of two independent groups that AID may play a niche role in accelerating 
reprogramming of iPS cells. 
 This biological observation does not come without due scrutiny.  The conclusions of the 
two separate groups stem from the use of fibroblasts derived from AID knockout mice (190, 191).  
AID is located in a pluripotency locus in close proximity to Nanog and other genes that play an 
important role during reprogramming.  While AID is the only gene removed in the knockout 
condition, one cannot exclude the possibility that important enhancers or non-coding RNAs that 
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regulate expression of the neighboring pluripotency genes were removed as well (192).  This 
concern is partially addressed by rescue experiments in which exogenous delivery of a retroviral 
vector containing AID is able to rescue the reprogramming process, with a catalytically-inactive 
version of AID unable to rescue the phenotype. 
 As reprogramming is proposed to depend on mC deamination, we may further test this 
hypothesis by rescue with the AID-3AL variant.  The Bhagwat group has already demonstrated 
that this chimera has increased mC deaminase activity relative to wild-type AID (195).  Our 
preliminary results indicate that this is increased mC tolerance is conferred by the A3A hotspot 
targeting loop.  One would predict this variant to achieve greater mC deaminase activity and 
confer a greater capacity for reprogramming.  Rather than attempting to rescue with A3A alone, 
this variant is uniquely positioned to contribute this answer because the AID donor mediates 
potentially critical interactions with actively transcribed DNA via Spt5 and RPA.  Rescued 
reprogramming with this variant would be indicative that mC deamination contributes to the DNA 
demethylation process and supportive of the role of AID in the niche of iPS. 
 There are a few additional controls that would be required if evidence pointed towards 
AID’s role in mC deamination in iPS cells.  A fundamental difference between wild-type AID and 
the A3A hotspot loop chimera is the sequence specificity of deamination targeting.  While AID 
normal prefers to deaminate C in the WRCY hotspot, the A3L loop variant has a targeting that is 
skewed closer to that of A3A: YCA.  It is possible that this manipulated sequence targeting could 
have a profound effect on reprogramming, independent of augmented mC deaminase activity.  To 
control for this possibility, and additional experimental condition will need to be evaluated using 
the AID-3GL construct.  This chimera has a similar sequence targeting to that of A3A, but is 
predicted to have reduced tolerance of mC.  This condition could serve as a control for altered 
sequence targeting of the AID-3AL chimera: if mC deamination truly is contributory to 
reprogramming, we would expect to see rescue from AID-3AL but not AID-3GL.  However, it is 
possible that sequence-specific deamination is more important that overall mC deaminase 
activity, in which case wild-type AID would preferentially rescue reprogramming over both 
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chimeric variants. 
 These experiments would demonstrate how our biochemical insights could provide new 
tools for evaluating the novel biological roles for AID in DNA demethylation.  While these studies 
would certainly require biochemical validation of the assumptions made above with regards to 
sequence targeting and mC tolerance, they provide an opportunity to use biochemical insights to 
investigate questions of importance to those studying AID, genomic stability and regenerative 
medicine. 
5.3.2 Evaluation of Proposed Role of AID/APOBECs in Cancer 
 A pro-mutagenic role for APOBECs has been proposed for breast cancer (131, 196, 
197).  This originates from sequence analysis in breast cancer genomes that identified a 
significant burden of mutations at TCA and CCA motifs, the preferred sequence targets of many 
APOBEC3 family members.  Further work from the Harris group has demonstrated a role for A3B 
in this mutagenesis through shRNA knockdown studies in primary cell lines and a combination of 
over-expression and shRNA knockdown studies in transformed breast cancer cell lines (131).  
While it does not provide the same compelling sense of certainty that comes with studies of 
endogenous systems, the ability to evaluate the pro-oncogenic potential of a deaminase through 
cellular over-expression provides a model in which chimeric variants can be used to assess the 
pro-oncogenic role of the deaminases.   
5.4 Concluding Remarks 
 The work described in this thesis presents a starting point for the detailed elucidation of 
the AID/APOBEC deamination reaction.  Here, we have demonstrated the important nucleic acid 
determinants of deamination.  2’-substitution to the nucleotide sugar disfavors cytosine for 
deamination, presumably through effects on nucleotide sugar pucker.  This selectivity appears to 
be important at the target cytosine and neighboring nucleotides as well.  5-substitution of the 
cytosine base is disfavored for deamination, presumably through steric clash within the margins 
of the active site.  Both of these nucleic acid selectivities are conserved across the entire 
AID/APOBEC family, indicated that the mechanism of deamination remains unchanged within the 
104	  
	  
family despite their different biological functions.  These insights support a model of deamination 
that illuminates future mechanistic studies into the deamination reaction.  Additionally, our 
biochemical insights may be used to complement cellular studies of AID/APOBEC function, 
particularly in regards to novel proposed roles outside of immunity. 
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